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ABSTRACT 
 
Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) that recognize 
pathogen-associated molecular patterns (PAMPs). The recognition leads to the activation 
of TLR signaling pathway, which initiates innate immune responses and facilitates the 
activation of adaptive immune responses. To control the immune response, the regulation 
of TLR activation is critical but is not well understood. Recent evidence has suggested 
that autophagy could regulate TLR signaling, but the underlying mechanism is not clear. 
Autophagy is a process of degrading intracellular components through lysosomal 
machinery to maintain homeostasis under stress conditions, and MAP1S is a recently 
characterized autophagy-related protein. We found that MAP1S deficiency in 
macrophages impaired cell membrane TLR activation and TLR mediated phagocytosis of 
bacteria. MAP1S interacts directly with MyD88 to regulate TLR signaling pathway. 
Furthermore, we demonstrate that, upon TLR activation, MyD88 is recruited to autophagy 
processing by co-localizing with LC3. Thus we reveal that an autophagy-related molecule 
MAP1S regulates TLR signaling. 
To take advantage of TLR-mediated innate immune responses to prevent 
infectious diseases, we set out to boost innate immunity against influenza. TLR9 agonist 
CpG-ODN in combination with TLR2 agonist Pam2CSK4 can induce innate resistance 
against lethal influenza A virus infection; however, the mechanisms are unclear. We found 
that in lung epithelial cell lines, pretreatment with CpG-ODN but not Pam2CSK4, 
inhibited influenza A virus infection. Surprisingly, CpG-ODN induced antiviral effect is 
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TLR9-MyD88 independent. Also, other intracellular DNA sensors including STING, 
DDX58, and DNA-PKcs are not required for CpG-ODN induced antiviral effect. 
Intriguingly, we found that CpG-ODN induced antiviral activity occurred at the early stage 
of influenza A virus life cycle. Together, our findings demonstrate that CpG-ODN inhibit 
influenza A viral infection in lung epithelial cells in a TLR9-MyD88 independent manner. 
Thus, we identified an autophagy protein MAP1S to regulate TLR signaling 
pathway. We also found that boosting innate immunity with TLR agonists can prevent 
infectious diseases, and TLR9 ligand CpG-ODN can induce a robust antiviral activity in 
lung epithelial cells. Therefore, this strategy may eventually help develop a novel 
therapeutic agent against influenza. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Immunity and Toll-like Receptors 
 
Overview of immune system 
The immune system is a complex interactive network of organs, tissues, cells and 
chemicals which has evolved to protect the host from infections. Functionally, the immune 
system can recognize and eliminate a limitless variety of foreign invaders, trigger a series 
of immune responses to battle infection and maintain homeostasis (Medina, 2016; Parkin 
and Cohen, 2001). The immune system also mobilizes immune responses to toxins and 
allergens. The fundamental principle of the immune system is to discriminate between self 
(host’s cells and proteins) and non-self (foreign molecules). A healthy state of the host 
requires a tight control and regulation of the immune system. Failure to tolerate self or 
nonresponse to non-self will cause immune disorders such as autoimmune diseases and 
immunodeficient diseases.  
A pathogenic microorganism must circumvent a series of coordinated immune 
events to establish an infection and cause diseases. These immune responses involve the 
participation of various structural, cellular and molecular components that can be divided 
into two categories: innate immunity and adaptive immunity (Figure 1). Innate immunity 
(also called “non-specific immunity”) provides the first line of defensive mechanisms. It  
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Figure 1. Immunity overview 
Immunity consists of innate immunity and adaptive immunity. Innate immunity 
provides an immediate but nonspecific response to invading pathogens. The major 
components of innate immunity are epithelial barriers, cytokines, chemokines, 
antimicrobial peptides and innate immune cells. The adaptive immune response is 
slower but antigen-specific. Adaptive immunity includes cellular and humoral 
immunity. 
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mounts rapid but non-specific immune responses against pathogens. Moreover, the innate 
immune system plays a crucial role in the initiation and subsequent activation of highly 
specific but relatively slow adaptive immunity(Janeway CA Jr, 2001). Adaptive immunity 
(also called “acquired immunity”) includes humoral immunity (B cells and antibodies) 
and cellular immunity (T cells). B cells (B lymphocytes) mature in the bone marrow and 
are activated in secondary lymphoid organs such as spleen and lymph nodes. When B cells 
are activated, they secrete antibodies specific to the antigens. T cells have various types 
and play a central role in cell-mediated immune responses. The functions of T cells 
include: direct elimination of infected cells, attack on foreign invaders, augment of B cells, 
and production of cytokines. Another characteristic of adaptive immunity is the 
immunological memory which elicits a rapid and robust response on the second infection 
of a pathogen and provides the host a long lasting protection.  
Since the initiation of adaptive immunity takes several days, the innate immune 
responses are vital in the first days immediately following exposure to pathogens. 
Moreover, in order to activate adaptive immunity, activation of innate immunity appears 
to be essential (Paul, 2011). 
 
Innate immune system 
The innate immune system is comprised of diverse defensive mechanisms against 
infection in vertebrates. The skin and the mucosal surfaces provide mechanical barriers to 
prevent the entry of pathogens. Skin is capable to prevent the penetration of most 
microorganisms although some pathogens can cause skin infection. Epithelial cells of 
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mucous membrane on alimentary and respiratory tract secrete fluids called mucus to trap 
pathogens. The cilia of the respiratory tract help to remove those trapped pathogens out of 
host body. Nonpathogenic commensal bacteria (known as normal flora) help maintain host 
homeostasis and prevent pathogens to reduce the probability of infection. In addition, 
antimicrobial peptides which are secreted by those surface barriers, have broad spectrum 
antimicrobial activity against pathogens such as bacteria, viruses and fungi. However, if 
the surface barriers are damaged such as a wound or some organisms have evolved 
escaping mechanisms, the pathogens are able to invade the host body. A variety of innate 
immune components including innate immune cells and their secreted soluble factors 
contribute to innate immune clearance of the pathogens that have entered the host. 
Lysozyme is one of the soluble factors found in tears, saliva mucus as well as in 
the cytoplasmic granules of macrophages and polymorphonuclear neutrophils. It acts as 
glycoside hydrolases and attacks bacteria by cleaving the peptidoglycan layer of the 
bacterial cell wall (McKenzie and White, 1991). Deficiency in lysozyme in airway 
secretion may cause bronchopulmonary dysplasia (Revenis and Kaliner, 1992). On the 
other hand, excessive production of lysozyme is toxic to blood and kidney. 
The complement system is comprised of a group of serum proteins that circulate 
in the blood. When stimulated, the complement proteins are converted from an inactive 
state to an active state by a series of proteolytic cleavage. Activation of complement 
system triggered by the classical, lectin or alternative pathways results in the following 
immune functions: opsonization and facilitating phagocytosis of pathogens by 
phagocytes; production of anaphylatoxins that attracts innate immune cells to the infection 
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site; damaging the membranes of pathogenic organisms for killing (Sarma and Ward, 
2011).  
Central players in the innate immunity are the innate immune cells which include 
macrophages, neutrophils, dendritic cells, Natural killer cells (NK cells), mast cells, 
eosinophils and basophils (Figure 2). Microorganisms that penetrate the surface barriers 
are targeted by innate immune cells to active an innate immune response. The major 
functions of the innate immune cells are recognizing pathogens to secret biologically 
active molecules such as cytokines to affect the behavior of other cells and chemokines to 
attract other immune cells, ingesting and destroying microbes directly, and facilitating the 
activation of adaptive immune cells by presenting antigens (Akira, 2009; Guermonprez et 
al., 2002; Janeway and Medzhitov, 2002; Lacy, 2015). 
Macrophages, a type of phagocytes, are differentiated from monocytes. 
Macrophages are distributed in almost all tissues. Some macrophages that reside in 
specific tissues are given various names such as alveolar macrophages in the lung, Kupffer 
cells in the liver, histiocytes in the connective tissues, osteoclasts in the bone tissues, and 
mesangial cells in the kidney (Davies et al., 2013; Haldar and Murphy, 2014; Perdiguero 
et al., 2015). Other macrophages are circulating within tissues or patrolling by amoeboid 
movement such as peritoneal macrophages. Two types of macrophages (M1 and M2) have 
been defined with distinct roles in inflammatory responses (Italiani and Boraschi, 2014; 
Martinez and Gordon, 2014; Mills, 2012). Macrophages engulf and digest invading 
pathogens through a process called phagocytosis for direct clearance.  
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After digesting the pathogens, macrophages will present antigens from the 
pathogens to T cells through MHC I/II molecules. In addition, the interaction between 
costimulatory molecules on macrophages (B7-1/2) and T cells (CD28) help to facilitate 
the activation of adaptive immunity (Martinez-Pomares and Gordon, 2007; Orlikowsky et 
al., 2003; Unanue, 1984). At the site of infection, macrophages are activated to produce a 
variety of inflammatory cytokines such as IL-1β, IL-6 and TNFα, and chemokines such 
as MCP-1 and IL-8 which will recruit other immune cells (Stow et al., 2009). The role of 
macrophages in the regulation of immune responses is complex. Pro-inflammatory 
cytokines secreted by macrophages such as IL-6, IL-18 and TNFα could promote the 
activation of T cells, B cells and NK cells, while anti-inflammatory cytokines secreted by 
macrophages such as IL-10 could inhibit the activation of immune cells (Arango Duque 
and Descoteaux, 2014; Ding et al., 1993; Fiorentino et al., 1991; Shi and Pamer, 2011). 
Macrophages have also been shown to manipulate cancer cells (Pollard, 2004; Richards 
et al., 2013), and play a role in wound healing and tissue regeneration (Godwin et al., 
2013; He and Marneros, 2013; Koh and DiPietro, 2011; Leibovich and Ross, 1975).  
Neutrophils are another type of phagocytes derived from myeloid precursors in the 
bone marrow. They are the most abundant type of circulating leukocytes in humans (50% 
to 70%). Neutrophils are short-lived cells comparing with other immune cells such as 
macrophage and only can live 1 to 3 days, but their daily production can reach up to 2.5 x 
1011 cells (Cartwright et al., 1964; Moore et al., 1979). Neutrophils are a type of 
granulocytes which form distinct subsets of granules within the cytoplasm that contains 
pro-inflammatory proteins and enzymes to kill microbes and to digest tissues (Borregaard, 
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2010). Their nucleus is segmented and multi-lobulated. Together with eosinophil and 
basophil, they are called polymorphonuclear cells (PMNs). Neutrophils are generally 
among the first leukocytes to be recruited to the infection site. To reach the inflammatory 
site, the neutrophils need to cross the vascular wall and extravasate to the tissues. This 
process requires several steps. Neutrophils are loosely attached to the surface of 
endothelium and activated by various chemoattractants such as chemokines (e.g. IL-8 and 
MIP-1β) which trigger signals inducing conformational changes in the integrin molecules 
on the neutrophils membrane. This process increases the neutrophils’ affinity with 
endothelium and the interactions between integrins and cell adhesion molecules (CAMs) 
enables the cell attached firmly. Subsequently, the neutrophils migrate transendothelially 
through the vessel wall into the inflammatory tissues. Once neutrophils reach the infection 
site, they eliminate the microbes by multiple mechanisms. After phagocytosis of 
microorganisms, neutrophils undergo a process called respiratory burst (or oxidative 
burst) rapidly releasing reactive oxygen species (ROS) by activating NADH and NADPH 
oxidase (Clark, 1999; Dahlgren and Karlsson, 1999). NADPH oxidase can reduce oxygen 
to generate superoxide anion, hydrogen peroxide and other toxic species, which have 
strong antimicrobial activity. Neutrophils also utilize myeloperoxidase (MPO) in the 
granules to produce hypochlorous acid from hydrogen peroxide and chloride anion which 
has a direct antimicrobial effect. Neutrophils also have a diverse group of antibacterial 
peptides such as defensins, lactoferrin, cathelicidin, and lysozyme (Falloon and Gallin, 
1986; Hager et al., 2010; Miles et al., 2009). Besides, neutrophils can release a 
combination of processed histones, proteins and enzymes (neutrophil elastase and 
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antimicrobial peptides) to form a structure called neutrophil extracellular traps (NETs). 
The process of forming NETs is called NETosis. NETs have been shown to immobilize 
bacteria and fungi and directly kill those microorganisms (Brinkmann et al., 2004; 
Brinkmann and Zychlinsky, 2012). 
Dendritic cells (DCs), another member of phagocytes, are present in major organs 
such as skin, lung, heart and spleen. Dendritic cells are a type of professional antigen 
presenting cells (APCs). They are essential in the recognition of a universe of antigens 
and control of innate and adaptive responses. Dendritic cells capture and process antigens 
to be recognized by T cells through MHC molecules (Figure 3). Two major subsets of 
dendritic cells have been identified: conventional DC (cDC) and plasmacytoid DC (pDC). 
They differ in their phenotype and functions (Liu et al., 2009). pDCs are a small subset of 
DCs that are fully developed in the bone marrow and they circulate mainly in the blood 
and lymphoid tissues (Shortman and Naik, 2007). pDCs express pattern recognition 
receptors such as TLR7 and TLR9 and produce large amounts of type I IFN upon virus 
infection or nucleic acids stimulation (Gilliet et al., 2008; Ito et al., 2005; Perussia et al., 
1985). pDCs express low levels of MHC II molecules and costimulatory molecules. They 
are not sufficient to stimulate naïve T cells unless activated as cDC-like cells (Liu, 2005). 
Precursors of cDCs are called pre-cDCs which derive from bone marrow and migrate to 
peripheral lymphoid organs where they differentiate into cDCs. cDCs are known to initiate 
and orchestrate adaptive immune responses by activating primary T cells (Steinman and 
Witmer, 1978). cDCs are found in both lymphoid and peripheral tissues and they have a 
high MHC class II expression (LeibundGut-Landmann et al., 2004; Young et al., 2008). 
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Figure 3. Innate immunity facilitates activation of adaptive immunity 
Recognition of pathogens by PRRs such as TLRs on antigen presenting cells triggers 
downstream signaling pathways leading to NF-κB activation, resulting in the 
production of inflammatory cytokines and chemokines. Antigens are processed and 
loaded onto MHC class I/II molecules, which activate adaptive immune cells. APCs 
also express co-stimulatory molecules to facilitate activation of adaptive immune 
cells. 
 11 
 
cDCs are found immature with accumulated MHC class II in endosomes and lysosomes. 
When immature cDCs take up pathogens, they become mature, with dramatically 
increased expression of cell membrane MHC class II and co-stimulatory molecules and 
decreased endocytic activity. Peptides derived from antigens process by cDCs are loaded 
on MHC class II and presented to CD4+ T cells. 
 
Toll-like receptors 
Immunologists used to believe that the adaptive immune system (with T cells and 
B cells) alone was able to recognize stimuli and mount immune responses. However, an 
unneglectable fact is that a foreign antigen alone is not sufficient to induce the adaptive 
immune responses without the addition of “nasty” adjuvants such as mineral oil, alum and 
killed mycobacteria. It raised the question why the lymphocytes failed to recognize “non-
self” antigens alone. This phenomenon that immunologists did not intend to admit was 
termed as “immunologist’s dirty little secret.” Back to 1980s, Charles A. Janeway, Jr. 
(1943-2003), a professor of immunology at Yale and Howard Hughes Medical Institute, 
proposed that activation of the adaptive immunity would require an additional signal from 
the “adjuvants.” He suggested that the additional signal was from non-lymphocyte cells, 
prior to the adaptive immunity. The “adjuvants” or other substances such as 
lipopolysaccharide could trigger the additional signal rapidly, and this process was not 
involved with receptor rearranging. He believed that on the innate arm, there must be a 
system recognizing certain characteristics or patterns rather than specific antigen 
determinants, and such receptors should be distributed non-clonally on antigen presenting 
 12 
 
cells (Janeway, 1989). He proposed the theory of pattern recognition receptors (PRRs) on 
APCs could discriminate self from infectious non-self. 
Charles’ hypothesis shed light on the studies of innate immune recognition. Within 
less than two decades, multiple pattern recognition receptor families had been identified 
(Table 1). They were found to recognize pathogens associated molecular patterns 
(PAMPs) which are conserved microbial patterns derived from bacteria, viruses, fungi and 
parasites, in exactly the same way as Charles proposed. Five families of PRRs have been 
classified so far including Toll-like receptors (TLRs), nucleotide-binding domain, leucine-
rich repeat (LRR) – containing (NOD-like) receptors (NLRs), RIG-I-like receptors 
(RLRs), C-type lectin receptors (CLRs), and the AIM2-like receptors (ALRs) (Brubaker 
et al., 2015). These PRRs are located either on the cell surface or intracellularly detecting 
conserved microbial patterns such as lipoproteins, LPS, flagellin and nucleic acids. Upon 
recognition of PAMPs, PRRs initiate downstream signaling pathways, which lead to the 
production of pro-inflammatory cytokines, chemokines, and interferons that are critical 
for innate and adaptive immune responses (Lander et al., 2001). 
Toll-like receptors are the first characterized member of PRRs family. TLRs owe 
their names to a fruit fly Drosophila melanogaster gene “Toll”, which was initially 
identified to be only involved in the differentiation of dorsoventral axis of the embryo 
(Hashimoto et al., 1988). Several years later after Charles’ hypothesis, the antifungal 
peptide Drosomycin in fruit fly appeared to be regulated by Toll. Jules A. Hoffman and 
colleagues found that Toll mutants were highly susceptible to fungi infection due to a lack 
expression of Drosomycin (Lemaitre et al., 1996). The cytoplasmic domains of Toll were 
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Family Members Location Shared 
domains 
Ligands Origin of Ligands Reference 
TLR 
(1-10)in 
human 
(1-9) 
and 
(11-13) 
in 
mouse 
TLR1 Cell membrane LRR, 
TIR 
Triacyl lipoprotein Bacteria (Alexopoulou et al., 
2001; Aliprantis et al., 
1999; Hayashi et al., 
2001; Heil et al., 2004; 
Hemmi et al., 2000; 
Mathur et al., 2012; 
Oldenburg et al., 2012; 
Poltorak et al., 1998; 
Song et al., 2015; 
Yarovinsky et al., 
2005) 
TLR2 Cell membrane Lipoprotein Bacteria, viruses 
TLR3 Endosome dsRNA Virus 
TLR4 Cell membrane LPS Bacteria 
TLR5 Cell membrane Flagellin Bacteria 
TLR6 Cell membrane Diacyl lipoprotein Bacteria, viruses 
TLR7 Endosome ssRNA Bacteria, viruses 
TLR8 Endosome ssRNA Bacteria, viruses 
TLR9 Endosome CpG-DNA Bacteria, synthetic 
TLR10 Endosome Unknown Unknown 
TLR11 Cell membrane Profilin-like 
proteins; flagellin 
Protozoa; bacteria 
TLR13 Endosome rRNA, ssRNA Bacteria, viruses 
CLR Dectin-1 Cell membrane C-type 
lectin 
β-Glucan Fungi (Goodridge et al., 
2009; Ishikawa et al., 
2013; Yamasaki et al., 
2008) 
Dectin-2 Cell membrane β-Glucan Fungi 
MINCLE Cell membrane SAP130 Fungi 
RLR RIG-I Cytoplasm DExD/H 
helicase 
dsRNA Viruses (Gitlin et al., 2006; 
Hornung et al., 2006; 
Li et al., 2009) 
MDA5 Cytoplasm dsRNA Viruses 
LGP2 Cytoplasm dsRNA  Viruses 
NLR NOD1 Cytoplasm LRR, 
NACHT 
iE-DAP Bacteria (Chamaillard et al., 
2003; Girardin et al., 
2003; Inohara et al., 
2003) 
NOD2 Cytoplasm MDP Bacteria 
ALR AIM2 Cytoplasm PYRIN,
HIN200 
dsDNA  (Hornung et al., 2009; 
Unterholzner et al., 
2010) 
IFI16 Cytoplasm, 
nucleus 
dsDNA Viruses 
 
 
Table 1. Pattern recognition receptor families 
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found to be highly conserved with the mammalian IL1 receptor. Toll signaling pathway 
also shows similarity with NF-κB signaling pathway downstream of the IL-1 receptor 
(Belvin and Anderson, 1996). These suggest that Toll pathway plays a role in regulating 
fruit fly immune responses. Shortly after discovering the function of Toll in fruit fly 
immunity, Charles and Medzhitov identified the human homolog of the drosophila Toll 
(Medzhitov et al., 1997). Subsequently, more TLRs, as well as their ligands were 
discovered (Chuang and Ulevitch, 2001; Chuang and Ulevitch, 2000; Du et al., 2000; 
Rock et al., 1998; Takeuchi et al., 1999). 
TLRs are a family of type I transmembrane receptors containing three domains: 
N-terminal ectodomain, a transmembrane domain and C-terminal cytoplasmic domain 
(Figure 4) (Bell et al., 2003). The N-terminal ectodomain is either extracellular or in the 
endosome characterized by a horseshoe-like structure. It has a motif in the inner concave 
surface known as the leucine-rich repeat (LRR) which is responsible for recognition of 
pathogens molecules (Jin et al., 2007; Kobe and Kajava, 2001; Liu et al., 2008; Park et al., 
2009). The C-terminal cytoplasmic domain is also known as Toll IL-1 receptor (TIR) 
domain because it shares homology with IL-1 receptor family (O'Neill and Bowie, 2007). 
After binding with ligands, TLRs dimerize and recruit adaptor proteins to TIR domain to 
activate downstream signaling pathways. 
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Figure 4. Schematic diagram of TLR structure 
TLRs are type I integral membrane glycoproteins. The structure of TLRs consists 
of three domains: N-terminal ectodomain (ECD), single transmembrane domain and 
C-terminal cytoplasmic domain (TIR domain). TLR ECD is built from leucine-rich 
repeats and recognizes PAMPs. TIR domain has 3 conserved boxes and is used for 
interaction with downstream adaptor proteins. 
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In human, 10 TLRs have been identified (Figure 5, Table 1). TLR1, TLR2, TLR4 
TLR5 and TLR6 are localized on cell membrane, whereas TLR3, TLR7, TLR8 and TLR9 
were localized within endosomes. TLR2 forms heterodimer with TLR1 or TLR6 to 
recognize bacterial lipoproteins, TLR3 recognizes dsRNA and poly (I: C), TLR4 together 
with co-receptor MD2 recognizes lipopolysaccharides (LPS), TLR5 recognizes flagellin, 
TLR7 and TLR8 recognizes ssRNA, and TLR9 recognizes unmethylated CpG motifs in 
microbial DNA. The ligand for TLR10 has not been identified so far, and the role of 
TLR10 has been suggested to be anti-inflammatory (Jiang et al., 2016; Oosting et al., 
2014).  
One or two of four TIR domain-containing adaptor proteins (MyD88, TRIF, 
TIRAP/Mal and TRAM) are recruited to TLRs upon ligands stimulation. Depending on 
the adaptor protein being recruited, TLR signaling could be divided into MyD88-
dependent signaling pathway and TRIF-dependent signaling pathway. All TLRs except 
TLR3 signal through MyD88 and TLR3 signals through TRIF. TLR4 triggers both 
MyD88-dependent and TRIF-dependent signaling pathways. 
MyD88 (Myeloid differentiation primary response gene 88) is indispensable for 
the signaling of all TLRs except TLR3. MyD88 is recruited to TIR domain of TLRs. TLR2 
and TLR4 require TIRAP/Mal to facilitate recruitment of MyD88 (Fitzgerald et al., 2001). 
MyD88 interacts with a serine/threonine kinase IL-1R-associated kinase IRAK4 and 
activates IRAK1 and IRAK2 (Kawagoe et al., 2008). The IRAKs complex then dissociates 
from MyD88 and interact with an E3 ubiquitin protein ligase TNFR-associated factor 6 
(TRAF6). TRAF6 catalyzes itself and activates the complex of TGF-β-activated kinase 1 
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(TAK1), TAK1-binding protein 1 (TAB1), TAB2, and TAB3. The complex 
phosphorylates IκB kinase (IKK) - β, MAP kinase kinase 3 (MKK3), MKK4, MKK6 or 
MKK7. The IKK complex phosphorylates and degrades IκB-α which allows translocation 
of NF-κB to the nucleus, thus further activate the expression of pro-inflammatory cytokine 
and chemokine genes such as IL-1, IL-6, IL-8 and TNFα. MKK3 or MKK6 activates p-
38/CREB and MKK4 or MKK7 activates JNK/AP-1, respectively. 
TLR3 recruits TRIF upon stimulation, while TLR4 requires TRAM to facilitate 
recruitment of TRIF (Yamamoto et al., 2003b). TRIF interacts with another E3 ubiquitin 
ligase TRAF3 which activates TANK-binding kinases 1 (TBK 1) and IKK-ε (Hacker et 
al., 2006; Yamamoto et al., 2003a). TBK1 and IKK-ε further phosphorylate IFR3 and IRF 
which are responsible for expression of type I interferons expression and interferon-
inducible genes. 
 
TLRs and immunity 
TLRs are widely expressed in epithelial and innate immune cells. TLRs triggers 
innate immune responses upon recognition of PAMPs from pathogens or DAMPs 
(Damage-associated molecular pattern) from the host, and lead to the production of 
cytokines and chemokines, which recruit immune cells such as macrophages and 
neutrophils to the inflammation site. During virus infection, activation of endosomal TLRs 
result in the production of type I interferons and activate IFN-inducible genes. Stimulation 
of TLRs in phagocytes increased phagocytic activity and intracellular bacterial killing 
(Doyle et al., 2004; Ribes et al., 2010). Stimulation of epithelial cells TLRs could produce 
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Figure 5. Toll-like receptors and TLRs mediated signaling 
TLRs recognize PAMPs derived from pathogens. TLR signaling is triggered by 
ligand-induced dimerization. All TLRs except TLR3 utilize MyD88 as the adaptor 
protein, whereas TLR3 and TLR4 utilize TRIF. Engagement of adaptor proteins 
activates IRAKs and TRAFs, which lead to the activation of MAPKs JNK and p38, 
NF-κB, or IRFs. TLR signaling results in the induction of pro-inflammatory 
cytokines or IFNs. 
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antimicrobial peptides in response to bacteria or LPS challenge (Ayabe et al., 2000; 
Birchler et al., 2001; Lehrer and Ganz, 2002). Peripheral immature DCs have strong 
endocytic activity to uptake pathogens. Microbial ligands activate TLRs on DCs to 
facilitate their maturation (Hertz et al., 2001; Michelsen et al., 2001). Activation of TLRs 
on DCs also induces expression of co-stimulatory molecules such as B7.1/B7.2 as well as 
inflammatory cytokines such as IL-12 (Akira et al., 2001). IL-12 could direct TH cells 
differentiation into TH1 effector cells. Mature DCs express high MHC molecules. They 
migrate to draining lymph nodes where they present the antigens to naïve T cells, thus 
facilitating the activation of adaptive immunity (Banchereau and Steinman, 1998; 
Steinman, 2001). 
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CHAPTER II 
CHARACTERIZATION OF AUTOPHAGY PROTEIN MAP1S IN THE 
REGULATION OF TLR SIGNALING AND PHAGOCYTOSIS* 
 
Introduction 
 
Autophagy 
Autophagy (from the Greek words: auto means “self” and phagy means “to eat”) 
is a conserved catabolic process of self-degradation of intracellular component through 
the lysosome machinery. Under harsh conditions such as nutrient deprivation, organelles, 
cytoplasm and cellular proteins are engulfed by a double-membrane vesicle called 
autophagosome, which is then delivered to the lysosome for degradation. This process 
promotes the recycling and salvage of nutrients to maintain cell homeostasis (Glick et al., 
2010; He and Klionsky, 2009; Kaur and Debnath, 2015). Multiple types of autophagy, 
including macroautophagy, microautophagy, and chaperone-mediated autophagy have 
been characterized. In this study, the term “autophagy” refers to macroautophagy unless 
otherwise specified.  
The membrane dynamics during autophagy are highly conserved (Figure 6). The 
process of autophagosome formation and subsequent fusion with lysosome are tightly 
regulated by autophagy-related genes (ATGs). In autophagy, initiation starts when 
                                                 
* A part of the work presented in this chapter has been published in The Journal of Biological 
Chemistry (Shi et al., 2016) 
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cytoplasmic components are sequestered by isolation membrane (or phagophore). The 
membrane is mainly from the endoplasmic reticulum (ER), and also perhaps from other 
sources such as mitochondria, nuclear membrane and plasma membrane (Mari et al., 2011; 
Militello and Colombo, 2011; Tooze and Yoshimori, 2010). The initiation site is also 
known as phagophore assembly site (PAS) (Kofinger et al., 2015; Suzuki and Ohsumi, 
2003). Formation of PAS is mediated by the ULK1 complex (ULK1-ATG13-FIP200- 
ATG101). Further nucleation requires the activation of autophagy-specific class III PI3K 
complex (Beclin1-ATG14L-VPS14-VPS34). Maturation of autophagosome requires the 
complex of ATG-ATG12-ATG16L and PE-conjugated LC3. The complete 
autophagosome then fuses with the lysosome, leading to the formation of autolysosome 
in which the cargos are degraded (Mizushima, 2007; Xie and Klionsky, 2007). 
  
Autophagy in immunity 
Autophagy plays important roles not only in the cellular metabolic and 
homeostatic function but also in immunity. However, the connection between autophagy 
and immunity seems to be complex and is not fully elucidated. Autophagy appears to 
orchestrate immunity in diverse regulatory systems (Figure 7).  
Autophagy facilitates direct elimination of intracellular microorganisms. LC3 
associated phagocytosis (LAP) is a process in which LC3 is recruited to the phagosomal 
membrane after phagocytosis of pathogens. Pathogens engage PRRs to trigger LAP which 
requires members of autophagic machinery such as class III PI3K complex, ATG5 and 
ATG7 (Martinez et al., 2015; Romao and Munz, 2014). LAP effectively promotes the 
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clearance of pathogens including bacteria, viruses, mycobacteria and fungi (Gong et al., 
2011; Lerena and Colombo, 2011; Sanjuan et al., 2007). Another mechanism is through 
selective autophagy, also termed as xenophagy, which engulfs the pathogens into 
autophagosome and delivers the pathogens to the lysosome for subsequent killing. 
Xenophagy has been shown to target invasive bacteria in both phagocytic and non-
phagocytic cells (Nakagawa et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Process of autophagy 
Autophagy is initiated when cytoplasmic organelles are sequestered by an isolation 
membrane which further forms an autophagosome. The autophagosome then fuses 
with the lysosome to form autolysosome where the internal material is degraded. 
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Figure 7. Autophagy in immunity 
The major functions of autophagy in immunity. Pathogens in the cytoplasm can be 
eliminated by autophagic machineries such as LAP and xenophagy. Autophagy can 
deliver PAMPs to endosomal TLRs and activate inflammatory signaling. 
Autophagy can enhance the antigen presentation by MHC class II molecules. 
Secretion of immune mediators from pre-stored granules is regulated by autophagy-
related proteins. 
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Autophagy broadly controls inflammatory signaling with various mechanisms. 
Autophagy machinery is required for the recognition of cytosolic viral replication 
intermediates by TLR7 and IFNα production by pDCs (Lee et al., 2007). ATG5-ATG12 
negatively regulates RLR-mediated induction of type I IFN production. ATG9A 
negatively regulates the activation of STING which is required type I IFN production in 
response to double-stranded DNA (Saitoh et al., 2009). In autophagy-deficient cells, p62 
accumulation interacts with TRAF6 to promote the activation of NF-κB and pro-
inflammatory signaling (Moscat and Diaz-Meco, 2009; Moscat et al., 2006; Sanz et al., 
2000). It is reported that autophagy negatively regulates inflammasome activation. 
Depletion of the autophagic proteins such as beclin 1 and LC3B enhances activation of 
caspase-1 and production of IL-1β and IL-18 through interfering with mitochondrial DNA 
(Nakahira et al., 2011). Production of IL-1β and IL-18 is increased in ATG16L1-/- and 
ATG7-/- mouse macrophages after TLR4 stimulation (Saitoh et al., 2008). Activation of 
autophagy limits the IL-1β secretion by eliminating ubiquitinated inflammasome (Shi et 
al., 2012). Secretion of IL-1α is increased ATG5 deficient macrophages in a calpain-
dependent pathway (Castillo et al., 2012). Selective autophagy of the adaptor protein 
BCL-10 modulates TCR to activation of NF-κB signaling (Paul et al., 2012).  
Autophagy delivers intracellular proteins to the lysosome for degradation and 
contributes to endogenous antigen presentation by MHC class II molecules (Jagannath et 
al., 2009; Jin et al., 2014; Schmid et al., 2007). Autophagy is also necessary for MHC 
class II-dependent processing and presentation of extracellular antigens (Lee et al., 2010). 
LAP and NOD2 have been shown to enhance autophagic antigen presentation (Cooney et 
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al., 2010). In addition, autophagy affects the secretion of immune mediators. Autophagy 
manipulates ER to Golgi apparatus secretory pathway to affect the secretion of IL-6 and 
IL-8 (Narita et al., 2011).  
Perturbations in autophagy are suggested to occur in inflammatory and 
autoimmune diseases. Genome-wide association studies have linked autophagic gene 
polymorphisms to Systemic Lupus Erythematosus (SLE) (Gateva et al., 2009; Han et al., 
2009; International Consortium for Systemic Lupus Erythematosus et al., 2008). Defects 
in autophagy protein function contribute to the pathogenesis of Crohn’s disease, a chronic 
inflammatory disorder of the small intestine. For example, autophagy protein ATG16L1 
and IRGM polymorphisms confer a strong risk of developing Crohn’s disease (Hampe et 
al., 2007; Lees et al., 2011; Murthy et al., 2014; Plantinga et al., 2011; Rioux et al., 2007).  
 
Autophagy and TLRs 
TLRs are innate immune sensors for recognizing pathogens-derived PAMPs. 
Recent evidence has linked TLR signaling to the induction of autophagy (Figure 8). It has 
been shown that stimulation of TLR signaling activates autophagy processes. For instance, 
activation of TLR4 by LPS induces the formation of LC3 associated autophagosomes and 
promotes the clearance of mycobacteria in macrophages (Xu et al., 2007). This process is 
dependent on TRIF but not MyD88 and then signals through RIP1 and p38 MAPK. 
Stimulation of TLR7 with Imiquimod or ssRNA induces autophagy in a MyD88 
dependent manner (Delgado et al., 2008). Beclin 1 is shown to interact with MyD88 and 
TRIF to facilitate the induction of autophagy after TLR engagement (Shi and Kehrl, 2008). 
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Other TLR ligands including zymosan, pam3csk4, poly (I: C), flagellin and MALP-2 are 
also able to induce autophagy or LC3 associated autophagic structures. TLR signaling also 
mediates autophagic elimination of microbe (Figure 9). TLR2 recognizes zymosan to 
induce LAP by recruiting autophagic protein LC3, ATG5 and ATG7 to phagosome to 
eliminate fungi (Sanjuan et al., 2007). TLR2 signaling is also shown to trigger autophagic 
clearance of Listeria monocytogenes in a MyD88-ERK dependent manner (Anand et al., 
2011). TLR4 and TLR7 engagement reduce mycobacteria viability in macrophages 
through autophagic machinery (Gutierrez et al., 2004; Xu et al., 2013).  
Our understanding of how autophagy regulates TLR induced signaling is limited. 
Autophagy delivers cytosolic single-stranded viral RNA to endosomal TLR7 to stimulate 
type I IFN response (Lee et al., 2007). Autophagy protein SQSTM1 and HDAC6 support 
MyD88 aggregation and suppress TLR4-induced activation of p38 and JNK signaling 
(Into et al., 2010). Another autophagy-related protein NDP52 mediate autophagic 
degradation of TRIF and TRAF6 to suppress TLR3/4 induced activation of IRF3 and NF-
κB signaling (Inomata et al., 2012). However, how other autophagy-related protein 
regulate TLR signaling is unclear.  
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Figure 8. TLRs induce autophagy 
Autophagy can be induced directly by TLR agonists. Activation of TLR2 and TLR7 
induce autophagy in a MyD88-dependent pathway. Activation of TLR3 and TLR5 
induce autophagy in a TRIF-dependent pathway. In addition, various TLR ligands 
can induce LC3-associated structure.  
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TLR2 signaling recruit ATG5 and LC3 to LAP to facilitate clearance of zymosan. 
Activation of TLR2 also promotes autophagic clearance of Listeria monocytogenes 
in a MyD88-ERK dependent manner. TLR4 and TLR7 induced autophagy reduce 
mycobacteria viability through TRIF-RIP1-p38 and MyD88-Beclin1 signaling, 
respectively. LPS induces selective xenophagy to eliminate Salmonella in a TRIF-
TRAF3-TBK1-OPTN pathway. 
Figure 9. TLR signaling mediates autophagic elimination of microbes 
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Microtubule-associated protein 1S (MAP1S) 
MAP1S (previously termed as C19ORF5) belongs to the microtubule-associated 
protein 1family. It is ubiquitously expressed in a wide range of tissues and organs. MAP1S 
binds to actin and stabilizes microtubules (Orban-Nemeth et al., 2005). MAP1S also binds 
to double stranded DNA through its microtubule binding domain (Liu et al., 2005). It is 
suggested that MAP1S plays a role in microtubule dynamics, mitochondria activity, 
mitotic abnormality and tumor development (Dallol et al., 2007; Jiang et al., 2015; Shi et 
al., 2014; Xie et al., 2011b). Recent evidence has shown that MAP1S is an autophagy-
related protein. MAP1S affect autophagosomal biogenesis and degradation (Liu et al., 
2012; Xie et al., 2011a). MAP1S interacts with LC3 and regulates autophagy flux. Here, 
by utilizing MAP1S KO macrophages that derived from MAP1S deficient mice, we will 
characterize the role of autophagy protein MAP1S in the regulation of TLR signaling. 
 
Phagocytosis 
Phagocytosis is a process by which phagocytes uptake extracellular particles 
within a plasma-membrane envelope known as phagosome. Phagocytosis is an ancient 
innate defensive mechanism against invading pathogens (Gordon, 2016; Greenberg and 
Grinstein, 2002; Jutras and Desjardins, 2005). A variety of innate immune cells are 
classified as phagocytes including macrophages, dendritic cells and neutrophils (Figure 
10A). Phagocytosis facilitates direct clearance of microorganisms. Microbes such as 
bacteria are engulfed into phagosome, which is then fused with the lysosome containing 
digestive enzymes (Figure 10B). 
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Phagocytosis is a receptor-mediated process (Flannagan et al., 2012). Numerous 
types of receptors such as PRRs, opsonic receptors, scavenger receptors and apoptotic 
corpse receptors have been shown to contribute to phagocytosis (Freeman and Grinstein, 
2014). Phagocytosis of bacteria is often accompanied by TLR induced inflammatory 
signaling. Previous reports showed that TLRs regulate phagocytosis by activating 
MyD88-p38 MAPK pathway to accelerate phagosome maturation (Doyle et al., 2004). 
Meanwhile, TLRs also regulate phagocytosis independent of MyD88 (Kong and Ge, 
2008). In addition, TLR2 is recruited to phagosomes during phagocytosis in macrophages 
(Underhill et al., 1999). Activation of TLR signaling increases phagocytosis of bacteria 
(Redlich et al., 2013). Activation of TLR2 and TLR9 signaling enhances the phagocytosis 
of E. coli and S. aureus (Doyle et al., 2004). A possible mechanism is through altering 
gene transcription programs associated with phagocytosis. Here, we will investigate the 
role of MAP1S in phagocytosis of bacteria. 
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Figure 10. Phagocytes and phagocytosis 
A B 
(A) Phagocytes include macrophages, dendritic cells, neutrophils and mast cells. 
(B) The process of phagocytosis of bacteria. Phagocytosis is a receptor-mediated 
process. Upon recognition, phagocytes engulf bacteria in a vacuole known as 
phagosome. Lysosome in the cytoplasm fuses with phagosome, releasing digestive 
enzymes into the phagosome to form the phagolysosome. Within the 
phagolysosome, microorganisms are killed and degraded. The digested contents 
are eliminated from phagocytes by exocytosis. 
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Materials and Methods 
 
Cells and reagent 
Raw264.7 and primary macrophages were maintained in DMEM supplemented 
with 10% FBS (HyClone). Peritoneal macrophages (PMs) were isolated from peritoneal 
lavage 5 days after intraperitoneal stimulation with 2 ml of 3% thioglycollate medium (BD 
Biosciences). Bone marrow-derived macrophages (BMDMs) were derived from bone 
marrows cells that were cultured in the presence of 10 ng/ml macrophage colony-
stimulating factor (R&D System) for 6 to 8 days. Bacteria strains Salmonella typhimurium 
SR11, Staphylococcus aureus Newman and Escherichia coli-GFP were cultured in LB 
medium. MAP1S antibody was purchased from Precision Antibody. IκB-α, phosphor-p38, 
and phosphor-Akt antibodies were purchased from Cell Signaling Technology. MyD88 
antibody was purchased from Imgenex. LC3 and p62 antibodies were purchased from 
MBL. LPS, ODN2216, and LTA were purchased from Invivogen. TRIzol for RNA 
isolation and Superscript II reverse transcriptase for cDNA synthesis were from 
Invitrogen. 
 
Mice 
MAP1S knockout mice in the C57BL/6 background were kindly provided by Dr. 
Leyuan Liu (Xie et al., 2011b). All mice were maintained at Texas A&M University 
Health Science Center in Houston, and all the experiments were performed by following 
the protocols approved by IACUC. 
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Phagocytosis assay 
Peritoneal macrophages or BMDMs were infected with S. typhimurium SR11 at 
MOI 10 to 1 and then the plate was centrifuged at 1000 rpm for 2min. The bacteria were 
allowed for phagocytosis for 30 min at 37 ℃. The cells were wash three times with PBS 
Then DMEM with 100 μg/ml gentamicin was added and incubated for 60 min. Then the 
cells were lysed in sterile water for 10min. Cell lysates containing phagocytosed bacteria 
were serially diluted and plated on LB plate. Bacteria colonies were counted the next day. 
 
Cell sorting and FACS analysis 
Splenocytes generated from C57BL/6 mice were stained with combinations of 
fluorescence-conjugated monoclonal antibodies (BD Biosciences), including B cells, 
CD19+; CD4 T cells, CD3+CD4+; NK cells, NK1.1+; macrophages, CD11b+F4/80+; 
dendritic cells, CD11c+CD11b+. Then, the splenocytes were sorted by FACSAria (BD 
Biosciences). BMDMs from WT and MAP1S KO mice were infected with GFP-E. coli 
(MOI 100: 1) for different time points. Then the cells were washed, fixed and analyzed by 
Flow Cytometry at the core facility at Brown Foundation Institute of Molecular Medicine 
(IMM), UTHSC. 
 
Immunofluorescence staining 
Macrophages (2 x 105 cells/well) were seeded in a 24-well plate containing 
coverslips and incubated overnight. At room temperature, the cells were washed and fixed 
in 4% paraformaldehyde for 10min and permeabilized with 0.5% Triton X-100 for 15min, 
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and then the cells were blocked with 5% BSA in PBS for 1h. The cells were then incubated 
with primary antibody at 4℃ overnight. Then the cells were washed with PBST for three 
times and incubated with fluorescence-conjugated secondary antibody for 1h at room 
temperature. After extensive washing, the cells were mounted with Aqua mount solution 
and images were analyzed with confocal microscopy (Zeiss). 
 
Immunoprecipitation and Western blot 
Cell lysates were incubated with protein G-Sepharose and indicated antibodies at 
4℃ overnight. Then the protein complexes were used for Western blot. Proteins were 
separated by SDS-PAGE and transferred to PVDF membrane. The membrane was blocked 
with 5% fat-free milk in TBST at room temperature for 30min and incubated with primary 
antibody at 4℃ overnight or 2 hours at room temperature. Then the membrane was washed 
in TBST for 3 times and incubated with HRP-conjugated secondary antibody for 1 hour. 
After extensive washing, the membrane was developed with ECL plus immunoblotting 
detection reagents (Amersham Biosciences). 
 
ELISA 
BMDMs from WT and MAP1S KO macrophages were stimulated with different 
TLR ligands or heat-killed bacteria, with the concentrations as indicated in the result 
section for 24 hours or 36 hours. Cell supernatant were collected and analyzed with 
respective ELISA kits following manufacturer instructions (R&D Systems). Briefly, 
ELISA plate was coated with capture antibody diluted in 100 ul coating buffer. The plate 
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was sealed and incubated at 4℃ overnight. On the next day, the plate was washed 3 times 
with washing buffer and then added 200 ul blocking buffer. The plate was incubated at 
room temperature for 1 hour. Then the plate was washed 3 times and 100 ul sample or 
standard was added to each well. The plate was incubated at room temperature for 2 hours. 
Then the plate was washed 5 times and 100 ul working detector was added to each well. 
The plate was incubated for 1 hour. Then the plate was washed 7 times and 100 ul substrate 
solution was added to each well. The plate was incubated for 30 minutes. Finally, 50 ul 
stop solution was added to each well and OD 450 nm was measured. 
 
Cell viability assay 
Cell counting kit-8 (Dojindo) was used to determine cell viability. Briefly, WT and 
MAP1S KO macrophages (2 x 104 cells/well) were seeded in a 96-well plate 24 hours 
before treatment. Then the cells were treated with indicated heat-killed bacteria or LTA 
for 24 hours. Then 10 μl of CCK-8 solution was added to each well of the plate and 
incubated at 37℃ until the desired color develops. OD 450 nm was then measured. 
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Results 
  
MAP1S regulates cell surface TLR signaling 
We examined the expression of MAP1S in different types of immune cells within 
the spleen. We found that MAP1S level in macrophages was relatively high comparing 
with other cell types including DCs, NK cells, T cells and B cells (Figure 11). TLRs 
expressed on macrophages recognize invading microorganisms and facilitate macrophage 
activation. This process initiates immune responses and is vital during infection. 
Autophagy has been suggested to be linked to TLRs (Into et al., 2012), but the molecular 
mechanisms are unclear. So we wonder whether autophagy protein MAP1S can regulate 
TLR signaling. 
Bone marrow derived macrophages isolated from C57BL/6 WT and MAP1S KO 
mice were challenged with heat-killed S. typhimurium (SR11) or TLR agonists: OSPA- 
TLR1/2, LTA- TLR2, poly (I: C)- TLR3, LPS- TLR4, flagellin- TLR5 and CpG ODN 
2216- TLR9 for 36 hours. The IL-6 and TNF-α level in the supernatant were evaluated by 
ELISA. We found that treatment with heat-killed bacteria and stimulation of cell surface 
TLR2 and TLR4 signaling secreted significantly less IL-6 and TNF-α in MAP1S KO 
macrophages than in WT macrophages (Figure 12A and Figure 13A). Activation of 
endosomal TLR3 and TLR9 signaling showed comparable cytokine secretion or type I 
IFN expression in both WT and MAP1S KO macrophages (Figure 12A,  Figure 13A and 
B). Flagellin failed to induce a response, which is consistent with the previous report that 
flagellin had no stimulatory effect on macrophages (Kwon et al., 2011).   
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Figure 11. MAP1S is highly expressed in macrophages   
 
Various types of immune cells were analyzed for MAP1S mRNA level by real-time 
RT-qPCR. Fold change is shown comparing with the expression level in the mouse 
liver. Single cell suspensions of splenocytes were sorted by FACS. All data 
represent mean ± SD. 
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Figure 12. Decreased IL-6 production in MAP1S deficient macrophages after cell 
surface TLR activation  
 
BMDMs generated from WT and MAP1S KO mice were treated with heat-killed 
S.typhimurium (HK-ST, 105 CFU/ml), LPS (100 ng/ml), LTA (10 μg/ml), OspA (50 
ng/ml), Flagellin (100 ng/ml), Poly (I:C) ( 100 ng/ml), ODN2216 (10 μg/ml) or 
untreated (A), or with indicated doses of LTA (B) or with LTA (10 μg/ml) for 
indicated time (C). IL-6 in the cell supernatant was measured 36 hours after 
stimulation by ELISA. All data represent mean ± SD. *p<0.05, **p<0.01. Unpaired 
t-test was used. 
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Figure 13. TNFα production decreased in MAP1S deficient macrophages after cell 
surface TLR ligands stimulation and type I interferon was unaffected  
 
A 
B 
(A) BMDMs generated from WT and MAP1S KO macrophages were treated with 
LTA (10 μg/ml) for 24 hours. TNFα in the cell supernatant was measured by ELISA. 
(B) BMDMs were treated with Poly (I: C) (1 μg/ml) for 4 hours, and IFNβ mRNA 
level was measured by real-time RT-qPCR. All data represent mean ± SD. *p<0.05, 
**p<0.01, ns-non-significant. Unpaired t-test was used. 
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We noticed that stimulation of TLR2 ligand LTA exhibited the most dramatic 
difference in cytokine secretion between WT and MAP1S KO macrophages. We further 
confirmed that upon LTA stimulation, IL-6 secretion in MAP1S KO BMDMs was 
significantly less than in WT BMDMs, both in time-dependent and dose-dependent 
fashion (Figure 12B and C). TLR1/2, TLR2/6, and TLR4 localize on the cell membrane, 
whereas TLR3 and TLR9 localize in the endosome. Stimulation with cell membrane TLR 
ligands caused a significant impaired signaling in MAP1S KO macrophages, while 
stimulation with endosomal TLR ligand showed no difference. These data suggest that 
autophagy protein MAP1S only affects cell surface TLRs activation. 
 
MAP1S controls the phagocytosis of bacteria in macrophages 
Macrophages are a type of phagocytic cells. They directly eliminate bacteria by 
phagocytosis during infection. Phagocytosis is a receptor-mediated process, and activation 
of TLRs has been shown to facilitate this process (Doyle et al., 2004; Ribes et al., 2010).  
Moreover, it is suggested that autophagy proteins might contribute to phagocytosis 
(Bonilla et al., 2013; Sanjuan et al., 2007). To investigate whether MAP1S affect 
phagocytosis of bacteria, we performed traditional phagocytosis assay by infecting 
primary peritoneal macrophages from WT and MAP1S KO mice with S. typhimurium. We 
found that phagocytosis of bacteria was impaired in MAP1S KO macrophages compared 
with WT macrophages (Figure 14A, B and C). We also infected WT and MAP1S KO 
macrophages with Texas-red stained bacteria and analyzed the phagocytosed bacteria with 
confocal microscopy. MAP1S KO macrophages phagocytosed fewer bacteria than 
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A 
B C 
D 
Figure 14. Impaired phagocytosis of bacteria in MAP1S KO macrophages  
(A) Schematic diagram of plate count phagocytosis assay. Peritoneal macrophages 
from WT and MAP1S KO mice were infected with SR11 (MOI 10: 1), (B) 
representative images and (C) quantification of phagocytosis rate comparing with 
WT cells were shown. (D) Representative images of phagocytosis of Texas-red 
stained SR11 in peritoneal macrophages from WT and MAP1S KO mice. (E) 
Peritoneal macrophages from WT and MAP1S KO mice were infected with GFP-
E.coli (MOI 100: 1) for different time intervals. The number of phagocytosed 
bacteria was determined under confocal microscopy by counting GFP-E.coli in 200 
cells. (F) BMDMs from WT and MAP1S KO macrophages were infected with GFP-
E.coli (MOI 100: 1) for different time intervals and flow cytometry was performed 
to determine the phagocytosis of bacteria. All data represent mean ± SEM. 
**p<0.01. Unpaired t-test was used. 
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Figure 14. Continued 
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WT cells (Figure 14D). We further confirmed the results by assessing phagocytosis of an 
E. coli strain expressing GFP with confocal microscopy and flow cytometry (Figure 14E 
and F). MAP1S is reported to be important for mitochondrial stress which can affect cell 
viability during starvation (Xie et al., 2011a; Xie et al., 2011b).  However, in our study, 
the cell viability showed no significant difference between WT and MAP1S KO 
macrophages with or without TLR ligand stimulation (Figure 15). Taken together, these 
data suggest that MAP1S plays a role in immune events in macrophages by regulating cell 
surface TLR signaling and controlling bacterial phagocytosis. 
 
MAP1S interacts with MyD88 
MAP1S is expressed intracellularly in the cells including macrophages (Xie et al., 
2011a). To determine the mechanism of how intracellular protein MAP1S regulates cell 
surface TLR activation, we reasoned that it might be associated with components of the 
downstream signaling pathway. Upon TLR activation, one or more adaptor proteins are 
recruited to TIR domain of TLRs. In co-immunoprecipitation experiments, we found that 
MAP1S directly associated with MyD88 in RAW264.7 cells upon LTA stimulation 
(Figure 16A, B and C). Furthermore, LTA-induced upregulation of MAP1S was in parallel 
with the increasing expression level of MyD88 (Figure 16D). Collectively, these data 
indicate that MAP1S regulates TLR signaling and controls bacterial phagocytosis by 
interacting with adaptor protein MyD88.  
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Figure 15. MAP1S deficiency does not affect macrophage cell viability  
BMDMs were from WT and MAP1S KO mice were treated with heat-killed ST (105 
CFU/ml), heat-killed E.coli (105 CFU/ml) and LTA (10 μg/ml) for 24 hours. Then 
cell viability assay was performed. The data represent mean ± SD. 
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Figure 16. MAP1S interacts with MyD88 
Raw264.7 cells were stimulated with LTA for 0.5 hour or 24 hours. Cell lysates 
were immunoprecipitated with control IgG, MAP1S antibody (A and B), or MyD88 
antibody (C), followed by Western blot detecting MyD88 and MAP1S, respectively. 
(D) Western blot demonstrating the accumulation of MAP1S and MyD88 in WT 
macrophages after LTA stimulation. FL, full-length; HC, heavy chain; SC, short 
chain. 
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Next, we evaluated the activation of downstream signaling pathways. Stimulation 
of TLR2 signaling generally would lead to the activation of NF-κB, JNK or p-38. We 
found no difference in IκBα degradation between WT and MAP1S KO primary 
macrophages (Figure 17). In contrast, the phosphorylation level of p38 dramatically 
decreased in MAP1S KO macrophages (Figure 17). The results are consistent with 
previous reports that inhibition of p38 decreased the expression of cytokines and impaired 
phagocytosis by inhibiting phagosome maturation (Blander and Medzhitov, 2004, 2006). 
It has been reported that activation of P38 MAPK and Akt are negatively correlated. 
Overexpression of Akt abrogates p38 MAPK phosphorylation. Downregulation of Akt 
activation contributes to enhanced p38 MAPK activation (Liao and Hung, 2003; Rane et 
al., 2010). Indeed, after LTA stimulation, p38 MAPK was activated in MAP1S WT 
macrophages with no activation of Akt, while in MAP1S KO macrophages, activation of 
p38 MAPK decreased with significant upregulation of phosphorylated Akt. Therefore, 
these data indicate that MAP1S is involved in TLR signaling through regulation of p38 
MAPK pathway but not NF-κB pathway. 
 
MyD88 is recruited to TLR-induced punctate structure by MAP1S 
TLR signaling has been shown not only to regulate autophagy, but also to directly 
induce autophagy and autophagy protein associated punctate structures (Delgado and 
Deretic, 2009; Delgado et al., 2008; Into et al., 2012; Xu et al., 2007). We stimulated WT 
and MAP1S KO macrophages with LTA and evaluated the accumulation of MyD88 and 
autophagosome marker LC3. Intriguingly, LTA-induced MyD88 accumulation with 
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punctate structure in a MAP1S-dependent manner (Figure 18A). Remarkably, we also 
found that MyD88 co-localized with LC3 after LTA stimulation in a MAP1S dependent 
mode (Figure 18B). It is consistent with the previous report that TLR2 signaling induced 
autophagy and punctate structure is MyD88 dependent (Shi and Kehrl, 2008).  Taken 
together, the results indicate that MAP1S facilitates the recruitment and accumulation of 
MyD88 into autophagy process in response to TLR activation. 
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Figure 17. MAP1S regulates p38 but not NF-κB activation in the TLR signaling 
pathway 
BMDMs from WT and MAP1S KO mice were treated with LTA (10 μg/ml) and 
analyzed the protein level change of IκB-α, phosphor-p38 and phosphor-Akt by 
Western blot.  
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Figure 18. MyD88 is recruited into the processing of TLR-induced punctate 
structure by MAP1S 
(A) Representative images of immunofluorescence staining of MyD88 in WT and 
MAP1S KO peritoneal macrophages after LTA (10 μg/ml) stimulation for 24 hours. 
(B) BMDMs from WT and MAP1S KO mice were stimulated with LTA for 24 
hours and co-localization of MyD88 (red) and LC3 (green) was analyzed by 
confocal microscopy. Scale bar = 10 μm. 
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Discussion 
 
TLRs detect invading pathogens, trigger innate immune responses and facilitate 
antigen presentation to activate adaptive immunity. Autophagy is a cellular process of 
degrading its own components through the lysosomal machinery to maintain cell 
homeostasis under harmful conditions (Glick et al., 2010; Mizushima, 2007). Autophagy 
is also an ancient mechanism for clearance of intracellular pathogens. More evidence has 
suggested that autophagy functions in diverse aspects of immunity (Deretic et al., 2013; 
Levine and Deretic, 2007; Schmid and Munz, 2007). TLR signaling has been shown to 
activate autophagic process in macrophages which is dependent on MyD88 and TRIF 
(Delgado et al., 2008; Xu et al., 2007). TLR-induced immune responses are also regulated 
by autophagy, but the mechanisms are not fully understood.  
Our study demonstrates that an autophagy protein MAP1S regulates cell surface 
TLR activation by directly interacting with adaptor protein MyD88. MAP1S is a novel 
characterized autophagy protein that regulates autophagosome biogenesis and degradation 
and interacts with LC3 (Xie et al., 2011a; Xie et al., 2011b). Surprisingly, secretion of 
cytokines was significantly decreased in MAP1S KO macrophages upon TLR agonists 
stimulation. We found that MAP1S only affected cell surface TLR activation, but not the 
intracellular TLR3 and TLR9 signaling. To investigate how an intracellular protein could 
regulate cell membrane receptors activation, we examined TLR downstream molecules 
and found that MAP1S could interact with adaptor protein MyD88, which is recruited to 
TIR domain after TLR dimerization. A function of microtubule-associated proteins is to 
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facilitate cargo transportation in the cytoplasm. The result suggests that MAP1S is likely 
to aid the recruitment of MyD88 to TIR domain of TLRs. It provides evidence that an 
autophagy protein regulates TLR signaling. One interesting question is how MAP1S 
interacts with MyD88 and facilitates its recruitment after TLR activation. We also noticed 
that LTA-induced parallel accumulation of MAP1S and MyD88. This result indicates that 
TLR signaling might also induce MAP1S translational upregulation or protein stability in 
the cytosol, and in turn MAP1S aids TLR activation. 
Although LTA stimulation exhibited a dramatic difference in cytokine secretion 
between WT and MAP1S KO macrophages, the difference in LPS and OspA treated group 
was relatively mild. The underlying mechanism is unclear. One possibility is that MAP1S 
might also facilitate protein trafficking in TLR2 signaling. Of note, MAP1S only affects 
p38 MAPK signaling, but not NF-κB signaling after TLR2 activation. This indicates that 
MAP1S might not only interact with MyD88 but also downstream molecules in TLR2-
MyD88-p38 MAPK pathway. Given the data that Akt signaling and p38 MAPK signaling 
might be inversely related to previous reports, another possibility is that deficiency in 
MAP1S upregulates Akt signaling, which in turn inhibits p38 MAPK signaling.  
TLR signaling is important in mediating phagocytosis in macrophages. Our results 
also underscore the contribution of MAP1S to phagocytosis of bacteria. MAP1S 
deficiency dramatically impaired the efficiency of phagocytosis of both gram-positive and 
gram-negative bacteria. Together with the data that MAP1S affects p38 MAPK signaling, 
the results are consistent with previous reports showing that p38 MAPK modulates 
phagosome maturation in macrophages (Blander and Medzhitov, 2004; Doyle et al., 
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2004). The hypothesis is that MAP1S deficiency decreases TLR induced p38 MAPK 
signaling which affects phagosome maturation, thus downregulates phagocytosis of 
bacteria in macrophages. Autophagy proteins have been shown to be recruited to 
phagosome during maturation (e.g., LC3- associated phagocytosis) (Martinez et al., 2011; 
Martinez et al., 2015). MAP1S also interacts with LC3. Another possible mechanism is 
that since MAP1S affects autophagosome biogenesis, it might also affect phagosome 
biogenesis.  
Activation of TLR signaling could induce autophagy or autophagy protein 
associated structure. This process is reported to be dependent on MyD88 (Shi and Kehrl, 
2008).We found that MAP1S facilitated MyD88 accumulation in the cytoplasm. 
Moreover, after LTA stimulation, MyD88 co-localized with LC3 in WT macrophages, but 
not in MAP1S KO macrophages. It indicates that MAP1S recruits MyD88 and promotes 
autophagic process in response to TLR activation. 
Increasing evidence has shown the connections between TLR signaling and 
autophagy (Arroyo et al., 2013; Into et al., 2012; Kim et al., 2015). Studies have shown 
autophagy could be induced by TLR ligands and knocking out autophagy associated 
proteins could affect TLR signaling. However, the mechanisms of how autophagy controls 
TLR activation and downstream signaling are unclear. Here, our study shows that an 
autophagy-associated protein, MAP1S, could regulate cell surface TLR activation in 
macrophages. Deficiency in MAP1S decreased cytokine secretion after TLR ligands 
stimulation likely through the p38 MAPK signaling pathway. MAP1S deficient 
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macrophages showed an impaired efficiency of phagocytosis. MAP1S interacts with 
MyD88 and TLR induced MyD88 recruitment is facilitated by MAP1S (Figure 19).  
Our work opens avenues for understanding the connections between autophagy 
and TLR signaling. Our study also provides a rationale of how autophagy protein regulates 
TLR signaling.  
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Figure 19. Schematic diagram of the regulation of TLR signaling and phagocytosis 
by MAP1S 
MAP1S interacts with MyD88 to regulate cell surface TLR activation and control 
TLR mediated phagocytosis of bacteria. MAP1S regulates downstream p38 MAPK 
signaling to control pro-inflammatory responses. 
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CHAPTER III  
CPG-ODN INDUCED INNATE RESISTANCE AGAINST FLU 
 
Introduction 
 
Influenza overview 
Influenza (also called Flu) is a contagious respiratory disease caused by influenza 
virus. The influenza virus mainly infects respiratory systems such as nose, throat, and 
lungs, resulting in mild to severe symptoms such as fever, cough, sore throat, headaches, 
stuffy nose, fatigue and sometimes even death. Most researchers think that influenza is 
spread mainly by droplets containing virus particles made by infected people when 
coughing, sneezing or talking (Bridges et al., 2003; Nicas et al., 2005). Those aerosolized 
droplets (<5- 10 μm) reach host lower respiratory tract with high efficiency. The onset of 
symptoms begins in 1 to 4 days after exposing to influenza virus. People infected with 
influenza are susceptible to complications including bacteria pneumonia, ear and sinus 
infections. Influenza infection can also worsen long term medical conditions such as 
asthma, heart failure, and diabetes. Old people, young children, pregnant women and 
people with chronic medical conditions described above are at high risk of developing 
more severe flu-associated complications when infected. It is strongly recommended to 
get a flu vaccination each year to prevent influenza infection, as well as staying away from 
people who are already infected.  
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Although usually influenza is not a deadly disease, it can be catastrophic. During 
the 1918 - 1919 flu pandemics (also known as Spanish flu), an estimated 50 million people 
died with an approximately 20% to 40% population being infected worldwide (Johnson 
and Mueller, 2002). 10% to 20% of infected people died. It was one of the deadliest 
disasters described as “the greatest medical holocaust in history”. The 1957 - 1958 Asian 
flu pandemic outbreak originated in China and then spread worldwide. The estimated 
death was 1 million to 4 million. The 1968 -1969 Hong Kong flu pandemic killed 
approximately 1 million people. The elderly were especially vulnerable and had the 
greatest death rates.  
Humankind is still facing the threat of an influenza pandemic nowadays with the 
emergence of highly pathogenic avian influenza (HPAI) strains.  Widespread circulation 
of H5N1 has been monitored since its appearance, since it not only causes devastating 
influenza pandemics in avian populations but also has the potential of transmission to 
humans and other mammalian species, which makes the pandemic threat unpredictable. 
Epidemic outbreaks each year because of a process called “antigenic drift” which results 
in a new strain of virus with slight genetic changes occurring in both influenza A and 
influenza B viruses. In fact, studies have shown that the pandemic flu is caused by another 
process called “antigenic shift” resulting in a dramatically new subtype against which most 
people have no immunity (Gething et al., 1980; Treanor, 2004). Influenza outbreaks cause 
huge healthcare burden and economic loss. 
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Influenza A virus and replication 
Influenza viruses belong to the family of Orthomyxoviridae. Three types of 
influenza viruses have been identified to circulate in human populations: type A, B and C. 
Type B and C influenza almost exclusively infect human, whereas type A influenza infect 
a wide variety of animal species including swine, human and birds (Ito and Kawaoka, 
2000). All the major flu pandemics are caused by influenza A virus which is believed to 
be originated from avian: 1918-1919 Spanish flu (H1N1), 1957- 1958 Asian flu (H2N2), 
1968- 1969 Hong Kong flu (H3N2) and the bird flu (H5N1).  
The influenza virion is a spherical enveloped particle which consists of an outer 
lipid membrane and an inner viral core. The lipid bilayer is derived from host plasma 
membrane and contains 80% hemagglutinin, 17% neuraminidase and a small amount of 
matrix 2 protein. Hemagglutinin and neuraminidase are the determinants of the subtype of 
influenza virus and also important in inducing host immune responses. Beneath the lipid 
bilayer is matrix protein 1 that supports the envelope rigidity. The viral core contains viral 
RNA segments associated with RNA polymerase proteins and non-structural proteins 
(Szewczyk et al., 2014). The genome of influenza A virus contains eight segments of 
negative-sense single-stranded RNA, encoding 11 viral genes: hemagglutinin (HA), 
neuraminidase (NA), nucleoprotein (NP), matrix 1 (M1), matrix 2 (M2), polymerase 
acidic protein (PA), polymerase basic protein 1 (PB1), polymerase basic protein 2 (PB2), 
polymerase basic protein 1-F2 (PB1-F2), non-structural protein 1 (NSP1), and non-
structural protein 2(NS2/NEP) (Bouvier and Palese, 2008; Szewczyk et al., 2014). 
Influenza A virus only replicates in living cells. The viruses undergo replication in the 
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following stages:  virus adsorption and entry into the host cell, viral RNA import into 
nucleus, transcription and replication of the viral genome, assembly of new viral particles, 
and exiting host cells. The newly released viruses then infect other surrounding cells. 
 
Innate immune responses to influenza virus infection and therapeutic implications 
After entering the host respiratory system, the influenza virus is recognized by 
innate immune PRRs including TLRs, RIG-I and NOD-like receptors expressed in cells 
such as epithelial cells, macrophages, and pDCs. Activation of TLR3 in influenza virus-
infected lung epithelial cells induces the production of pro-inflammatory cytokines (Le 
Goffic et al., 2007). TLR7 recognizes influenza virion ssRNA genome and activates NF-
κB or IRF7 signaling (Diebold et al., 2004; Lund et al., 2004). RIG-I recognizes the 5’-
triphosphate viral ssRNA in the cytosol of influenza virus infected cDCs, macrophages 
and epithelial cells (Baum et al., 2010; Hornung et al., 2006; Kato et al., 2005; Pichlmair 
et al., 2006). Activation of PRRs during influenza infection induces expression of pro-
inflammatory cytokines, type I and type III interferons and interferon-stimulated genes 
(ISGs), which induce antiviral resistance and promote adaptive immune responses. 
The more specific and effective adaptive immunity produces a slower response 
than that of the innate immunity (Figure 20). When given a lethal dose of influenza virus 
infection, the host may not be able to generate an effective adaptive immune response in 
time for protection. The innate immunity is antigen-unspecific, however, provides the host 
immediate protection against influenza virus infection. An ideal strategy is to boost the 
innate immune system to induce innate resistance against influenza virus infection. 
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Figure 20. Immune responses after influenza virus infection 
Innate immune responses are triggered immediately after influenza virus infection. 
The innate immune responses include activation of pro-inflammatory signaling, 
production of cytokines, chemokines, and interferons, expression of ISGs and 
recruitment of innate immune cells. It takes days to weeks for the establishment of 
a specific adaptive immune response. 
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Indeed, previous studies have demonstrated that pretreatment with a combination 
of aerosolized TLR2/6 and TLR9 ligands (Pam2CSK4 and CpG-ODN, respectively) could 
induce a high level of innate resistance against both bacteria and influenza virus infection 
in mice (Duggan et al., 2011; Evans et al., 2010a; Tuvim et al., 2012). Of note, Pam2CSK4 
and CpG-ODN synergistically protect mice against lethal influenza A virus infection. The 
mechanisms are unknown, but it has been suggested that the lung epithelium rather than 
recruited leukocytes contributes to induced innate resistance (Evans et al., 2011). Here, 
we investigate the induced innate resistance against influenza A virus infection by one of 
the components CpG-ODN in vitro. 
 
CpG oligodeoxynucleotides 
CpG oligodeoxynucleotides (CpG-ODN) are short synthetic single-stranded 
oligodeoxynucleotides (ODN) that contain unmethylated CpG motifs (C: cytosine 
triphosphate deoxynucleotide; p: phosphodiester link or phosphorothioate (PS) link; G: 
guanine triphosphate deoxynucleotide) recognized by TLR9. CpG motifs are relatively 
common in the genomes of bacteria and DNA viruses. The immune-stimulatory activity 
of an ODN is determined by multiple characteristics. GTCGTT is the optimal CpG motif 
for the human while in mouse the optimal motif is GACGTT (Hartmann and Krieg, 2000; 
Krieg et al., 1995; Rankin et al., 2001). An optimal CpG-ODN sequence usually contains 
several CpG motifs (two intervening bases between each motif), TpC dinucleotide on the 
5’ end, pyrimidine repeats on the 3’ side and modified PS backbone (Ballas et al., 1996; 
 61 
 
Hartmann and Krieg, 2000; Hartmann et al., 2000; Pisetsky and Reich, 1998; Roberts et 
al., 2005). 
Three major classes of CpG ODN have been classified based on structural and 
biological characteristics: Class A, Class B and Class C. Class A ODN contain a central 
palindromic phosphodiester region and poly-G motifs at the 5’ or 3’ end which can form 
highly ordered structures. They induce strong activation of pDCs and expression of IFNα 
(Hartmann et al., 2003; Kerkmann et al., 2005). Class B ODN contain a full 
phosphorothioate backbone and are strong stimulators of B cells. Class C ODN combine 
both features of Class A and Class B ODN containing a palindromic region and fully 
phosphorothioate backbone. They activate both pDCs and B cells and induce IFNα 
secretion (Marshall et al., 2003). 
Previous reports showed that prior administration of inactivated avian H5N1 
influenza virus with a modified CpG-ODN could protect chickens effectively (Fu et al., 
2013). In addition, CpG-ODN enhances immune responses to influenza virus vaccine 
(Lopez et al., 2006; Mallick et al., 2011; Singh et al., 2016a; Singh et al., 2016b). 
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Materials and Methods 
 
Cell lines and reagents 
A549 cell line ((Adenocarcinomic human alveolar basal epithelial cells) was 
purchased from ATCC, and MLE15 cell line (Immortalized mouse lung epithelial cells) 
was kindly provided by Dr. Michael J Tuvim, University of Texas MD Anderson Cancer 
Center. A549 cells were maintained in F-12K medium (ATCC), whereas MLE15 cells 
were maintained in RPMI-1640 medium (Lonza). Both media were supplemented with 
5% FBS and 100IU/ml penicillin-streptomycin. PAM2CSK4 and ODN M362 were kindly 
provided by Pulmotect, Inc. ODN2216, ODN2006, ODN2395 and their respective ODN 
controls were purchased from Invivogen. Influenza A H3N2 antibody was purchased from 
Takara. Influenza A H3N2/HK/8/68 was a gift from Dr. Brian Edward Gilbert, Baylor 
College of Medicine. 
 
Mouse model 
The experiments with influenza infection were performed at BL2 animal facility 
by following the protocols approved by TAMHSC Institutional Animal Care and Use 
Committee (IACUC). In the in vivo experiment, the C57BL/6 mice were pretreated with 
aerosolized 2 μM ODN M362 and 8 μM Pam2CSK4 for 15 min with Aerotech II nebulizer 
flowing at 10 L/min air from an Easy Air compressor with drying coil (PM15F, Precision 
Medial). After 24 hours, the mice were infected with influenza virus aerosol (DMEM with 
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0.05% gelatin solution) calculated to deposit approximately 119 TCID50 per mouse for 20 
min. Morbidity and mortality were monitored for approximately 2 weeks.  
 
In vitro antiviral assays 
Cells (1x105/well) were seeded into a 24-well plate 24 hours before treatment in 
complete growth medium. Then, the cells were pretreated with 5 μM ODN M362 for 4 
hours in serum-free medium, and then H3N2 influenza virus was added (at ratio 1: 1) for 
another 24 hours. Real-time RT-qPCR or immunohistochemistry (IHC) were used to 
analyze the antiviral activities. 
 
Real-time qPCR and semi-quantitative PCR 
Total RNA was isolated from cells and supernatant with RNA isolation kit by 
following the instruction (OMEGA), and then the RNA was used to generate cDNA by 
reverse transcription (Quanta bio). Real-time qPCR was performed on Bio-rad IQ5 system 
by using SYBR green (Bioline) (Table 2). For semi-quantitative PCR, half of the 50 μl 
reaction products were electrophoresed on an agarose gel after 25 cycles, while the other 
half was electrophoresed after 35 cycles.  
 
Immunofluorescence staining 
A549 cells (1x105/well) were seeded on coverslips in 24-well plate. After influenza 
virus infection, cells were washed with PBS and fixed with 4% paraformaldehyde. The 
cells were permeabilized with 0.5% Triton-X100 for 10min and blocked with 1% BSA for 
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1 hour. The cells were incubated with H3N2 antibody at 4℃ overnight. Then the cells 
were incubated with anti-mouse FITC for 1 hour following DAPI staining for 5 min. Cells 
were washed with PBST for 3 times after each step. The coverslip was mounted on slide 
with Aqua Mount and analyzed by DeltaVision Elite imaging system (GE).  
 
Cell immunohistochemistry 
Cells were fixed on the coverslip in 4% paraformaldehyde for 15 min and treated 
with 0.3% H2O2 until bubbling stopped. Cells were incubated with blocking solution 
(Vectastain ABC kit) for 20 min. Then the cells were incubated with H3N2 antibody for 
45 min. Then the cells were incubated with biotinylated secondary antibody for 30 min. 
The cells were then incubated with HRP-conjugated avidin-biotin complex for 30 min. 
Next, the substrate solution (Vector novared) was added until suitable staining developed. 
Then the cells were counterstained with hematoxylin (Sigma) for 2 min and washed with 
water until blue color developed. Cells were washed with PBST for 3 times after each step. 
Air dry coverslip at room temperature for 10min and mount in Aqua Mount. 
 
ELISA 
Interferon lambda secretion was measured in influenza virus-infected cell 
supernatants. Briefly, a 96-well microplate was coated with capture antibody at room 
temperature overnight. The plate was washed with PBS the next day and blocked with 
reagent diluent for 1 hour. Cell supernatant was collected, added to the plate and incubated 
for 2 hours. Then detection antibody (R&D systems) was added and incubated for 2 hours 
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at room temperature. Aspiration/washing was performed after each step as the instruction. 
Then Streptavidin-HRP was added for 20 minutes. Stop solution was added and then 
measure absorbance at OD450nm using a microplate reader (SpectraMax M).  
 
CRISPR/Cas9 
To generate MyD88 and STING-deficient A549 cells, CRISPR/Cas9 was 
performed as described (Sanjana et al., 2014; Shalem et al., 2014). Three pairs of 
oligonucleotides for sgRNA were designed for each gene (Table 3). Plasmids used were 
kindly provided by Dr. Yubin Zhou, Institutes of Bioscience and Technology, Texas A&M 
University. Lentiviral CRISPR plasmid was digested and dephosphorylate with BsmBl 
(Fermentas) for 30 min at 37℃. The Gel with digested plasmid was purified using 
QIAquick Gel Extraction Kit and eluted in the elution buffer. Then each pair of oligos was 
phosphorylated and annealed as described (Sanjana et al., 2014; Shalem et al., 2014). 
Annealed oligos were diluted at 1:200 dilution and ligated with digested plasmid. Then 
the plasmid was transformed into and amplified in Stbl3 bacteria. All three plasmids were 
transfected into A549 cells with Lipofectamine 2000 (Life technology). After transfection, 
puromycin was added for selection. Then the cells were serially diluted into 96 well plate 
for the single clone. After selection and expansion of single clones, the gene expression 
level was tested with Western blot to confirm efficiency. 
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Western blot 
The expression of MyD88 and STING proteins in A549 cells were detected by 
Western blot analysis. Briefly, 40 μg of cell lysate proteins were used for each sample. 
Proteins were resolved on 10% SDS-polyacrylamide gels and transferred to PVDF 
membranes. The membranes were blocked with 1%BSA in TBST for 1hr at room 
temperature. Primary antibody (Cell signaling) diluted (1: 1000) in 1%BSA was added 
and incubated at 4℃ overnight. The membranes were washed 3 times for 5min each with 
TBST. The HRP-secondary antibody was then added and incubated at room temperature 
for 1 hour, followed by detection with ECL. The image was taken by FluorChem M 
System (Bucher Biotec). 
 
Cell proliferation and cytotoxicity assay 
Cell counting kit-8 (Dojindo) was used to determine cell proliferation and 
cytotoxicity. Briefly, 5000 cells were seeded in a 96-well plate for 24 hours. After 
treatment, 10 μl of CCK-8 solution was added into each well of the plate and incubated 
for in 37℃ incubator for 1-4 hours until desired color develops. Then, measure the 
absorbance at 450 nm using a microplate reader (SpectraMax M). 
 
Luciferase assay 
MLE15 cells were seeded in a 48-well plate 24 hours before transfection so that 
the cell confluence would reach 70% to 90% on the next day. On the following day, 0.05 
NF-κB luciferase reporter plasmid was delivered into the cells with Lipofectamine 2000 
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transfection reagent as instructed. On the third day, the cells were stimulated with 
Pam2CSK4, or ODN M362 for 8 hours. Then the cells were lysed and luciferase reagent 
(Promega) was added. The luminescence was measured by FLUOstar Optima microplate 
reader. 
 
 
 
            Table 2. Real-time qPCR primer 
 
 
 
 
 
 
 
Gene Sequence 
IAV forward GGACTGCAGCGTAGACGCTT 
IAV reverse CATCCTGTTGTATATGAGGCCCAT 
human GAPDH forward CGGATTTGGTCGTATTGGG 
human GAPDH reverse CGCTCCTGGAAGATGGTGAT 
mouse GAPDH forward GTTGTCTCCTGCGACTTCA 
mouse GAPDH reverse GGTGGTCCAGGGTTTCTTA 
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        Table 3. CRISPR/Cas9 sgRNA oligo sequences 
 
 
 
 
 
 
 
Gene Sequence 
MyD88 1F CACCGGTTCTTGAACGTGCGGACAC 
MyD88 1R AAACGTGTCCGCACGTTCAAGAACC 
MyD88 2F CACCGCTGCTCTCAACATGCGAGTG 
MyD88 2R AAACCACTCGCATGTTGAGAGCAGC 
MyD88 3F CACCGCTCGAGCAGTCGGCCTACAG 
MyD88 3R AAACCTGTAGGCCGACTGCTCGAGC 
STING 1F CACCGAGAGCACACTCTCCGGTACC 
STING 1R AAACGGTACCGGAGAGTGTGCTCTC 
STING 2F CACCGAAGGGCGGGCCGACCGCATT 
STING 2R AAACAATGCGGTCGGCCCGCCCTTC 
STING 3F CACCGAGGGCGGGCCGACCGCATTT 
STING 3R AAACAAATGCGGTCGGCCCGCCCTC 
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Results 
 
CpG-ODN and Pam2CSK4 protect mice against lethal influenza A virus infection 
Laboratory mouse strain C57BL/6 is highly susceptible to Influenza A virus (IAV) 
H3N2/HK/8/68 infections. The IAV pathogenicity and severity of IAV-induced disease 
depend on the challenge dose administered. Mice receiving a lethal dose of aerosolized 
influenza virus develop severe symptoms in several days characterized by lethargy, 
anorexia, and huddling. The infection results in massive weight loss and ultimately death. 
In the lethal influenza infection mouse model, pre-treatment with the combination of 
aerosolized TLR9 agonist (ODN M362) and TLR2/6 agonist (Pam2CSK4) protected mice 
from death (Figure 21A), while the single component alone resulted in no protection 
(Tuvim et al., 2012). Besides, weight loss in mice pretreated with ODN and Pam2 was 
significantly less than that of untreated mice (Figure 21B). Similar studies have been done 
in bacteria-induced pneumonia mouse model. Pretreatment with ODN and Pam2 in the 
lungs induced resistance to pneumonia associated with rapid pathogen killing. (Duggan et 
al., 2011; Evans et al., 2010a; Evans et al., 2011; Evans et al., 2010b; Tuvim et al., 2009). 
In these models, serial reductions in leukocyte lineages by antibodies or toxins did not 
impair the inducible protection while disruption of TLR signaling in the lung epithelium 
abrogated the resistance (Cleaver et al., 2014). Given the fact that influenza virus mainly 
targets the respiratory epithelium, it is possible that TLR agonists ODN and Pam2 may 
directly reduce the pathogenicity of influenza virus in lung epithelial cells. 
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A 
B 
Figure 21. CpG-ODN and PAM2CSK4 synergistically protect mice from infection 
with lethal dose of flu virus 
C57BL/6 mice were inhaled with aerosolized influenza virus (119 TCID50 per 
mouse) 24 hours after pretreatment with aerosolized ODN M362 and Pam2CSK4 
(concentration). (A) Survival proportions of untreated and pretreated mice (log-rank 
test, n=15/group) and (B) Body weight change (multiple t-test, n=15/group) were 
monitored daily. All data represent mean ± SEM; ***, p<0.001. 
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Lung epithelial cells play a critical role in CpG-ODN/Pam2CSK4-induced protection 
against influenza virus infection and CpG-ODN is the major component 
To investigate if CpG-ODN and PAM2CSK4 could exert a protective effect in 
alveolar epithelial cells, we established an in vitro model to mimic the in vivo studies 
utilizing human alveolar basal epithelial cell line A549 and mouse immortalized lung 
epithelial cell line MLE. Both of these two cell lines express TLR2 and TLR9 (Figure 
22A, B and data not shown). Cells were pretreated with the combination of CpG-ODN 
and Pam2CSK4 (“ODN-Pam2”) for 4 hours and then infected with influenza virus for an 
additional 24 hours (Figure 23A). As expected, ODN-Pam2 induced an antiviral effect in 
both cell lines, in which both virus particles (Figure 23B) and virus RNA level (Figure 
23C) were significantly reduced. Surprisingly, CpG-ODN appeared to be the major player 
in the protective effect in vitro while Pam2CSK4 played a very limited role (Figure 23B, 
C), although Pam2CSK4 induced a much stronger NF-κB signaling compared with CpG-
ODN M362 in MLE15 cells (Figure 24), as well as cytokine/chemokine expression 
(Tuvim et al., 2012). Given the synergistic protective effect by CpG-ODN and 
Pam2CSK4, it is possible that CpG-ODN induced antiviral activity in the lung epithelial 
cells might be one of the mechanisms of the protection effect in vivo.  
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A 
B 
Figure 22. TLR expression in human lung epithelial A549 cells  
  
(A) Semi-quantitative RT-PCR was used to determine TLR1-10 expression in A549 
cells. PCR products from PCR 25 cycles and 35 cycles were electrophoresed on 
agarose gel. (B) Real-time RT-qPCR of TLR1-10 expression in A549 cells.  
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Figure 23. Anti-influenza activity by CpG-ODN and PAM2CSK4 in respiratory 
epithelial cells  
(A) Schematic diagram of in vitro antiviral assays. Cells were pretreated with 
indicated TLR agonists for 4 hours and infected with influenza virus for additional 
24 hours. Cells were then fixed for IHC or lysed for RNA isolation. (B) 
Representative images of IHC of influenza infected cells with indicated 
pretreatment. Bafilomycin was shown to inhibit lysosome acidification, thus used as 
positive control to inhibit influenza replication. (C) Real-time PCR was performed 
to determine influenza RNA level in A549 and MLE cells with indicated 
pretreatment. All data represent mean ± SEM. *p<0.05, ***p<0.001. Unpaired t-test 
was used. 
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Figure 24. NF-κB activation induced by CpG-ODN and Pam2CSK4 in MLE15 
cells  
 
MLE15 cells were transfected with NF-κB reporter plasmid and analyzed for 
luciferase activity with indicated stimulation. All data represent mean ± SEM. 
*p<0.05, ***p<0.001. Unpaired t-test was used. 
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CpG-ODN-induced protection against influenza virus infection in lung epithelial cells 
We first used class A, B and C CpG-ODN to investigate whether they could induce 
antiviral activity in A549 cells (Figure 25A). Class B CpG-ODN ODN2006, Class C CpG-
ODN ODN2395, and ODN M362 exhibited strong antiviral activity against influenza 
virus infection, whereas class A CpG-ODN ODN2216 was less effective (Figure 25B). 
Class A CpG-ODNs strongly activate pDCs and induce high amount of IFN-α production, 
but are weak stimulators of TLR9 dependent NF-κB signaling (Krug et al., 2001). Class 
B CpG-ODNs strongly activate B cells but stimulate very small amounts of IFN-α 
secretion (Krieg et al., 1995). Class C CpG-ODNs combine the features of both Class A 
and B CpG-ODNs. A previous report showed that a class C CpG-ODN in combination 
with Pam2CSK, provided the most efficient protection against lethal influenza infection 
in vivo (Tuvim et al., 2012). Our observation in the antiviral assays here is consistent with 
previous result. 
To confirm the antiviral effect by class C CpG-ODN, the influenza virus RNA was 
evaluated by qRT-PCR. A reduction of 85% to 95% in influenza virus RNA was observed 
in ODN M362 pretreated cells (Figure 26A and B). Immunohistochemistry and 
immunofluorescence staining of influenza virus protein showed that fewer cells were 
infected after pretreatment with ODN M362 (Figure 25B and Figure 26C). Taken together, 
these data reveal a protective effect against influenza virus infection by CpG-ODN in lung 
epithelial cell lines. 
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Figure 25. CpG-ODN-induced protection against influenza virus infection in lung 
epithelial cells 
 
A 
B 
(A) CpG-ODNs were used in antiviral assays. (B) Representative IHC images of 
influenza virus-infected cells with indicated CpG-ODN pretreatment. Brown color 
indicates infected cells. Scale bar, 10μm. 
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Influenza RNA level in untreated and CpG-ODN pretreated (A) A549 cells and (B) 
MLE cells after influenza infection for 24 hours and 48 hours. All data represent 
mean ± SEM. **p<0.01, ***p<0.001. Unpaired t-test was used. (C) Representative 
images of untreated and CpG-ODN pretreated A549 cells after influenza infection 
for 24 hours. Scale bar, 10 μm. 
 
Figure 26. Protection with class C ODN M362 against influenza virus infection in 
A549 cells   
 
A 
C 
B 
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ODN M362 pretreatment decreased IAV-induced type III interferon secretion in lung 
epithelial cells 
Type I and type III interferons are activated rapidly during influenza virus 
infections (Killip et al., 2015; Lazear et al., 2015). The interferons upregulate hundreds of 
interferon-stimulated genes that efficiently inhibit virus replication and spread, thus 
restrict the early stage of influenza infections before the activation of adaptive immune 
responses (Iwasaki and Pillai, 2014). We detected limited upregulation of type I interferon 
after influenza infection in A549 cells (data not shown). However, type III interferon 
expression was robustly regulated (Figure 27A and B). Type III IFN is the predominant 
IFN produced by the epithelium and is only produced in infected cells (Crotta et al., 2013; 
Jewell et al., 2010; Okabayashi et al., 2011; Sommereyns et al., 2008). We found that IFN 
lambda expression was significantly less in CpG-ODN M362 (hence “CpG-ODN”) 
pretreated cells after influenza virus infection at both protein level and mRNA level 
(Figure 27A and B). Since CpG-ODN is not sufficient to induce IFN lambda expression 
(Ioannidis et al., 2013), the results suggested that antiviral effect by CpG-ODN and the 
related antiviral mechanism might occur before interferon secretion.   
 
Cell viability is not affected by CpG-ODN pretreatment 
To investigate if the observed protective effect is due to decreased cell viability 
possibly induced by CpG-ODN pretreatment, we evaluated A549 cell viability after CpG-
ODN stimulation. Although it was reported that CpG-ODN induced apoptosis in other cell 
types (Arunkumar et al., 2013; Zhang et al., 2014), we found no significant difference 
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A 
B 
Figure 27. CpG-ODN pretreatment decreased IAV induced IFN-λ expression in 
A549 cells  
 
(A) IFN lambda level in the supernatant of untreated and CpG-ODN pretreated 
A549 cells with or without influenza infection, as detected by ELISA. (B) IFN 
lambda mRNA level in untreated and CpG-ODN pretreated A549 cells after 
influenza infection, as detected by real-time RT-qPCR. Time point indicates 
infection time. All data represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001. 
Unpaired t-test was used. 
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between untreated and CpG-ODN-treated cells (Figure 28). Thus, the CpG-ODN induced 
protection against influenza virus infection in vitro is an early innate immune response 
irrelevant with cell viability. 
 
CpG-ODN induced antiviral effect is independent of TLR9-MyD88 signaling 
Since TLR9 can be functionally activated in A549 cells, we next wondered 
whether CpG-ODN-activated TLR9 signaling was responsible for the protective effect 
against influenza virus infection. Activation of TLR9 downstream signaling requires the 
key adaptor protein MyD88 (Akira and Takeda, 2004; Warner and Nunez, 2013). And 
MyD88 is indispensable for immune protection during influenza A virus infection in vivo 
(Seo et al., 2010). We first knocked down MyD88 in A549 cells by siRNA to evaluate if 
MyD88 was essential in CpG-ODN induced protection. Surprisingly, in MyD88 
knockdown A549 cells, CpG-ODN still elicited protection against influenza virus 
infection at a comparable level to control cells (Figure 29A, B and C). Fewer cells were 
infected of both control and MyD88 knockdown cells after CpG-ODN pretreatment, and 
also there was no significant difference in influenza RNA level.  
To further confirm this result to rule out the possibility that the observation is due 
to incomplete deletion of the functional MyD88 gene, we then generated MyD88 knockout 
A549 cells by CRISPR/Cas9 techniques to determine if MyD88 was not required in CpG-
ODN induced protection. With this method, MyD88 protein level was completely 
diminished in knockout cells (Figure 30B). Consistent with MyD88 knockdown results, 
CpG-ODN induced antiviral effect was not impaired in MyD88 knockout cells 
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Figure 28. CpG-ODN treatment does not affect A549 cell viability   
 
A549 cell viability was measured 24 hours after CpG-ODN treatment, as detected 
by CCK-8 kit. NS, non-significant. 
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(Figure 30A).  Taken together, we concluded that CpG-ODN induced protective effect in 
lung epithelial cell lines is independent of TLR9-MyD88 signaling.  
 
Non-TLR9 stimulatory GpC-ODN also confer antiviral effect 
TLR9 recognizes CpG motifs of ODN (Hemmi et al., 2000). To ask whether CpG-
ODN induced protection is characterized by TLR9 recognition, we used non-TLR9 
stimulatory GpC-ODN instead of CpG-ODN in the antiviral assays. The GpC-ODN 
contains GpC dinucleotides instead of CpGs and can be used as negative controls with 
their respective CpG-ODN. Notably, all GpC-ODN showed comparable antiviral effect 
with their CpG-ODN (Figure 31A, B and Figure 25B). We found that Class B and C GpC-
ODN induced stronger protection than Class A GpC-ODN, which was consistent with 
their respective CpG-ODN. These results showed that CpG-ODN induced protection did 
not go through TLR9 or its downstream signaling.  
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Figure 29. Protection by CpG-ODN from influenza infection in MyD88 
knockdown A549 cells  
A 
B C 
A549 cells were transfected with control siRNA or MyD88 siRNA. (A) 
Representative images of antiviral activity after CpG-ODN pretreatment in control 
or MyD88 knockdown cells. Different concentrations of ODN were used. (B) 
Knockdown efficiency determined by Western blot. (C) Influenza RNA level in 
control or MyD88 knockdown cells were detected by real-time RT-qPCR. 
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Figure 30. Protection by CpG-ODN in MyD88 knockout A549 cells. MyD88 
deficient cells were generated by CRISPR/Cas9 technique  
A 
B 
(A) Representative images of antiviral activity after CpG-ODN pretreatment in 
control and MyD88 knockout cells. (B) Protein level in control and MyD88 
knockout cells were detected by Western blot. 
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A 
B 
Figure 31. Non-TLR9 stimulatory GpC-ODNs also protect cells from influenza 
virus infection   
  
(A) Representative IHC images of antiviral activity after ODN or ODN controls 
pretreatment. (B) Quantification of virus-infected cells/total cells in (A). All data 
represent mean ± SEM. *p<0.05, **p<0.01. Unpaired t-test was used. 
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TBK1, DDX58 and STING are not responsible for CpG-ODN-induced antiviral effect in 
lung epithelial cells 
Next, we sought to investigate if other intracellular DNA sensors are responsible 
for CpG-ODN recognition and induced protection. It has been reported that DDX58 (also 
known as retinoic acid-induced gene I (RIG-I)), DAI (DNA-dependent activator of IFN-
regulatory factors) and STING (Stimulator of interferon genes) could also detect 
intracellular DNA and activate immune responsive signaling (Ablasser et al., 2009; Diner 
et al., 2013; Sun et al., 2013; Takaoka et al., 2007). DDX58 induces type I interferon 
production after cytosolic DNA detection by RNA polymerase III. DAI senses 
cytoplasmic DNA and recruits IRF3 and TBK1, leading to interferon induction. Cyclic 
GMP-AMP senses cytosolic DNA and activates its adaptor protein STING to trigger 
antiviral immune responses. We generated DDX58, and TBK1 (the downstream effector 
of DAI) knockdown cells, and evaluated the antiviral effect of CpG-ODN pretreatment. 
We found no difference in the antiviral activity of control cells and knockdown cells. CpG-
ODN protected both knockdown cells from influenza infection (Figure 32A). In addition, 
STING-deficient cells showed no impairment in CpG-ODN induced antiviral activity 
(Figure 32B and C). As a result, CpG-ODN induced antiviral effect might not go through 
canonical DNA sensing pathways. Notably, these cytosolic DNA sensors mainly triggers 
type I interferon induction, while CpG-ODN induced antiviral mechanism appears to be 
interferon-independent.  
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Figure 32. TBK1, DDX58, and STING are not responsible for ODN-induced anti-
IAV activity  
 
A 
B C 
(A) Representative IHC images of antiviral activity in CpG-ODN pretreated control, 
TBK1 knockdown or DDX58 knockdown A549 cells. (B) STING-deficient A549 
cells were generated by CRISPR/Cas9. Representative IHC images of antiviral 
activity in CpG-ODN-pretreated control cells or STING deficient cells. (C) Protein 
level in control and STING-deficient cells were detected by Western blot. 
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CpG-ODN induced antiviral effect is NF-κB and STAT1 signaling independent 
Our results so far indicated that a non-canonical antiviral mechanism elicited by 
CpG-ODN, resulting in less cell infection and reduced viral particles. We wondered 
whether two most important antiviral pathways: NF-κB signaling and STAT1 signaling 
are dispensable for this phenomenon. Interestingly, knockdown of RELA (p65) in NF-κB 
signaling cascades, a key component for nuclear translocation and activation showed no 
impairment in CpG-ODN induced protection against influenza virus infection (Figure 33A 
and B). Knockdown of STAT1 did not affect CpG-ODN-induced protection against IAV 
either. (Figure 33C and D). These data further suggested that an unpredicted mechanism 
plays a role in CpG-ODN induced protection of lung epithelial cells from influenza virus 
infection. The activation of NF-κB activation after CpG-ODN stimulation and induction 
of type III interferon after influenza virus infection may be one of the explanations for the 
CpG-ODN-Pam2CSK4 induced protection in vivo, but unlikely to be the mechanism for 
the antiviral effect we observed in vitro. Given the data that fewer cells were infected in 
pretreated cells, CpG-ODN is likely to prevent infection events rather than eliminate the 
virus. ODN designed to target either influenza polymerase or translation complex has been 
reported to inhibit influenza virus replication (Kwok et al., 2009; Rodriguez et al., 2016). 
However, CpG-ODN were designed for immunostimulatory effect rather than targeting 
influenza or translational component. Its effect on the different stages of viral infection is 
unknown. 
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C 
B 
D 
Figure 33. CpG-ODN-induced anti-IAV activity does not go through NF-kB or 
STAT1 signaling  
 
(A) and (B) A549 cells were transfected with control or RelA siRNA and CpG-
ODN induced antiviral activity was detected by (A) IHC or (B) real-time RT-qPCR. 
(C) and (D) A549 cells were transfected with control or STAT1 siRNA and CpG-
ODN induced antiviral activity was detected by (C) IHC or (D) real-time RT-qPCR. 
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CpG-ODN-induced antiviral activity in lung epithelial cells occurs at early stage 
The life cycle of the influenza A virus from entering a cell to exiting a cell is a 
rapid the process involving multiple steps. To further characterize the infection process, 
we performed the time-lapse infection experiment. The viral particles started to increase 
markedly from 6 hours after infection (Figure 34A and B). The data were consistent with 
the previous report (Kamps et al., 2006). Comparing with untreated group, fewer cells in 
CpG-ODN pretreated group were infected at all-time points from 6 hours after infection 
(Figure 34A). The influenza virus RNA level in CpG-ODN pretreated group was also 
dramatically reduced than untreated group starting from 6 hours after infection (Figure 
34B). These data indicated that CpG-ODN induced antiviral effect occurred within the 
first life cycle of influenza virus replication, perhaps much earlier than the typical antiviral 
immune responses. 
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A 
B
Figure 34. Time-lapse influenza virus infection in A549 cells  
 
A549 cells were pretreated with CpG-ODN for 4hr and then infected with influenza 
virus for indicated time period. Antiviral activity was evaluated by (A) IHC and (B) 
real-time RT-qPCR. Time point indicates infection time. 
 
 92 
 
Discussion 
 
During the last few decades, boosting immune responses to induce protection 
against infection has been a central point of many studies. As one of the potent 
immunostimulatory agents, bacterial lysates have been introduced to evaluate the capacity 
of protection against infectious damages. In fact, immunization with bacterial lysates seem 
to be effective against microbial infections, especially in respiratory system infections 
(Evans et al., 2010a; Kikuchi et al., 2014; Mak et al., 1983; Spencer et al., 1977; Van Daal 
et al., 1991; van Daal et al., 1990; van Daal et al., 1992). Bacterial lysates are a mixture of 
bacterial antigens derived from one or more species. These antigens are recognized by 
PRRs and stimulate innate immune responses. The protection was associated with 
activation of innate immune cells, expression of inflammatory cytokines and chemokines, 
interferons and rapid pathogen killing. The rationale is further expanded by investigating 
the protective effect of the different combination of TLR agonists. We and multiple groups 
demonstrate that pretreatment with a combination of Pam2CSK4 (TLR2/6) and CpG-
ODN (TLR9) could induce a high level of resistance to lung infection by bacteria, 
influenza and fungi (Duggan et al., 2011; Tuvim et al., 2012). 
Similar innate immune responses are observed with other combinations, however, 
no dramatic protective effect is comparable with that of Pam2CSK4 and CpG-ODN. The 
mechanisms are not fully elucidated. It is suggested that Pam2CSK4 and CpG-ODN 
induced innate resistance to bacteria pneumonia appears to be mainly mediated by 
activated epithelial cells rather than recruited immune cells (Cleaver et al., 2014; Evans et 
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al., 2011; Evans et al., 2010b). Our studies show that pretreatment with Pam2CSK4 and 
CpG-ODN indeed confers an inhibitory effect on influenza virus infection in lung 
epithelial cells. Surprisingly, the inhibition is mainly induced by CpG-ODN, while 
Pam2CSK4 almost shows no effect. On the other hand, Pam2CSK4 induces higher 
activation of NF-κB signaling than CpG-ODN. Since single component could not induce 
innate resistance in vivo, it suggests that Pam2CSK4 induced signaling might work in an 
unknown mechanism synergistically with CpG-ODN. We further investigated the 
antiviral effect with different classes of CpG-ODN. Class B and C ODN induced 
comparable significant antiviral effect, while Class A ODN exhibited limited antiviral 
activity.  
TLR9 is functionally expressed in lung epithelial cells and activated by CpG-ODN 
(Droemann et al., 2005). Unexpectedly, CpG-ODN induced the antiviral effect in A549 
cells appears to be TLR9-MyD88 signaling independent. GpC-ODN controls exhibited 
similar resistance against influenza virus infection as CpG-ODN. GpC motifs do not 
stimulate TLR9 signaling and can be used as a negative control. Moreover, MyD88 
deficiency did not compromise CpG-ODN induced antiviral effect. Of note, we only found 
expression of type III IFN, but barely type I IFN. Type III IFN expression was significantly 
decreased in CpG-ODN pretreated cells. Since type III IFN is produced only in infected 
cells, it suggests that fewer cells are infected after CpG-ODN pretreatment. The IHC 
images also showed that CpG-ODN pretreatment significantly decreased the number of 
infected cells.  
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We checked other intracellular DNA sensors including STING, DDX58, TBK1 
and DNA-PKcs, and none of them was indispensable for CpG-ODN induced antiviral 
activity in lung epithelial cells. Furthermore, neither of pro-inflammatory NF-κB signaling 
or ISG related STAT1 signaling is involved in CpG-ODN induced antiviral effect, 
suggesting that it is not mediated by late produced cytokines or interferons. Indeed, by 
characterizing the dynamics of antiviral effect in a time-lapse fashion, we found that CpG-
ODN induced antiviral effect occurred within several hours after infection. Considering 
that the life cycle of influenza virus is only several hours, CpG-ODN seems to function 
very quickly.  
Currently, we are investigating the mechanism of how CpG-ODN contribute to the 
induced resistance to influenza infection in lung epithelial cells. Our observation from in 
vitro antiviral assay suggests that CpG-ODN pretreatment is more likely to prevent 
influenza virus from infecting cells or inhibit influenza virus replication rather than 
directly kill the virus. It is reasonable to assume that any step of the influenza viral life 
cycle could be inhibited. One possibility is that CpG-ODN pretreatment stimulates a rapid 
intracellular response to inhibit influenza virus replication. This process may involve 
upregulation of specific antiviral effectors. Another possibility is that CpG-ODN may 
directly interfere with influenza viral replication. Thus, it is important to investigate which 
step of influenza viral life cycle (binding, entry, uncoating, genome releasing and 
replication, transcription, translation, assembly, and egress) is inhibited. This CpG-ODN 
induced antiviral effect observed in vitro may contribute to Pam2CSK4 and CpG-ODN 
induced protection against influenza infection in vivo. 
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Our study shows that Pam2CSK4 and CpG-ODN induce a high innate resistance 
to a lethal dose of influenza virus infection in mice. Our study also shows that CpG-ODN 
inhibits influenza virus infection in lung epithelial cells, which is independent of TLR9-
MyD88 signaling. Our work provides implications for the therapeutic use of TLR agonist 
to boost innate resistance against infections. 
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CHAPTER IV 
CONCLUSIONS 
 
In the first part, we characterized an autophagy related-protein MAP1S in the 
regulation of TLR signaling. In macrophages, we found that MAP1S deficiency resulted 
in impaired cytokine secretion after activation of cell surface TLRs, but not endosomal 
TLRs. We also found that MAP1S deficiency decreased the efficiency of phagocytosis of 
bacteria in macrophages. Interestingly, MAP1S was shown to directly interact with a 
critical adaptor protein, MyD88. More intriguingly, we found that MAP1S appeared to 
affect p38 MAPK signaling, but not NF-kB signaling. Also, after TLR stimulation in 
macrophages, MAP1S facilitated MyD88 recruitment to autophagy protein LC3 
associated structures. These data suggest a previously unrecognized aspect in the 
connection between autophagy and TLR signaling 
In the second part, we concentrated on elucidating the mechanism underlying  
CpG-ODN induced resistance against influenza A virus in lung epithelial cells. CpG-ODN 
in combination with Pam2CSK4 protected mice from lethal influenza A virus infection. 
The combination also inhibited influenza A virus infection in vitro, and we noted that 
CpG-ODN was the active component. We found that pretreatment with Class B and C 
CpG-ODN significantly inhibited influenza A virus infection in lung epithelial cell lines. 
We found that CpG-ODN induced antiviral effect was TLR9-MyD88 signaling 
independent. We also showed that the antiviral effect did not go through other DNA 
sensors including DNA-PKcs, TBK1, DDX58, and STING. Furthermore, we noted that 
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CpG-ODN induced antiviral activity occurs at early stage during influenza life cycle. 
Thus, our data suggest a novel mechanism through which CpG-ODN protects lung 
epithelial cells from influenza infection. 
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